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1. Introduction
Each behavioral phenomenon in man, such as the perception of sensory
input, performance of motor output and cognitive function, is controlled by the
central nervous system (CNS). These processes are dependent on the
precise interaction of billions of neurons, which are generated during
embryonic development. While classical series of anatomical studies over a
century ago helped us to understand the structure and organization of the
nervous system, modern studies on the development of this most complex
organ are expanding the knowledge on the cellular and molecular processes
underlying the wonderful complexity of the mature nervous system.
1.1. Morphological organization of the central nervous
system during embryogenesis and at maturity
After the closure of the neural tube at late gastrulation the caudal part forms
the spinal cord, while anteriorly, three vesicles are formed: the
rhombencephalon, mesencephalon, and prosencephalon. The
rhombencephalon (hindbrain) gives rise to the pons, cerebellum and medulla
oblongata, its cavity becomes the fourth ventricle. The dorsal part of the
mesencephalon (midbrain) forms the tectum where colliculi superiores (the
rostral tectum) and colliculi inferiores (the caudal tectum) are formed, and
tegmentum where several nuclei are located.  The cavity of the
mesencephalon develops into the mesencephalic duct or cerebral aqueduct in
the adult brain. The prosencephalon (forebrain) subdivides into the
telencephalon and diencephalon (see also Table 1; Kandel et al., 2002). The
dorsal part of telencephalon forms the cortex (pallium), connected with the
olfactory bulb, while the ventral telencephalon (subpallium) gives rise to the
basal ganglia (striatum). In the diencephalon, the territory of the pretectum,
dorsal thalamus (with epithalamus), the ventral thalamus and hypothalamus
are distinguished (Table 1; Fig.1; Kandel et al., 2002).
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Spinal cord
Rhombencephalon
(Hindbrain)
Pons, Cerebellum, Medulla
oblongata
Brain stem
Mesencephalon
(Midbrain)
Tectum, Cerebral peduncle,
Pretectum, Mesencephalic
duct
Diencephalon Epithalamus, Thalamus,
Hypothalamus, Subthalamus,
Pituitary gland, Pineal gland,
Third ventricle
Brain
Prosencephalon
(Forebrain)
Telencephalon Basal ganglia, Amygdala,
Olfactory bulb, Hippocampus,
Neocortex, Lateral ventricles
Table 1. Organization of the CNS
Figure 1. General organization of the mammalian telecephalon
The schema represents the major subdivisions of the embryonic telecephalon in
sagittal (A) and coronal (B) views. LGE, Lateral Ganglionic Eminence, MGE: Medial
Ganglionic Eminence, POA: Preoptic Area. (Adapted from Marin, 2003).
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1.2. Patterning of the CNS during development
Figure 2. Activation-transformation model for establishment of the AP axis of
developing CNS
In the first step (before the beginning of gastrulation), the hypoblast (in chick)/anterior
visceral endoderm (AVE) (in vertebrates) specifies the prospective forebrain, “pre-
forebrain state”. During gastrulation, signals from the node and the early involuting
mesoderm stabilize the induced neural fate with anterior characteristics. During the
second step, signals from the lately involuting mesoderm cause transformation that
leads to acquisition of posterior neural fate characteristics. (Adapted from Stern,
2001).
Patterning of the developing CNS is a process of spatiotemporal
differentiation that ensures generation of cells of distinct fate in the correct
number, time and location. Establishment of CNS patterning is a long and
complex process that starts during gastrulation. Classical experiments in
Xenopus demonstrated that the neural fate is the “defaults state” of the
ectoderm, suppressed by BMP signaling between ectodermal cells. Inhibition
of BMP function by molecules (activin, noggin, follistatin), secreted by the
“organizer”, abrogates BMP signaling and leads to the induction of neural fate
with anterior characteristics (Wilson & Hemmati-Brivanlou, 1997; Streit &
Stern, 1999). The decisive role in this process
Introduction
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Figure 3. Prosomeres are defined by the expression of genes
The expression of six genes Dlx-2, Gbx-2, Nkx-2.1, Nkx-2.2, Otx-2, and sonic
hedgehog (sonic hh) in the neural plate (E8.5) and the neural tube (E10.5 and E12.5)
of the embryonic mouse brain are indicated. The fate map of the neural plate and
neural tube are based on the studies of gene expression pattern (reviewed by
Rubenstein et al., 1994). Neuroepithelium with molecularly specified expression of
transcription factors defines prosomeres. The forebrain is organized accordingly to
the prosomeres. The provisional transverse and longitudinal boundaries are shown
as thin black lines. D, diencephalon; E, eyes; H, rhombencephalon-hindbrain; I,
isthmus; M, mesencephalon-midbrain; os, optic stalk; p, prosomere; r, rhombomere;
sc, spinal cord; SP, secondary prosencephalon. (Adapted from Rubenstein et al.,
1994).
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has the organizer (in Xenopus), named the Hensen node (in chicken) or the
node (in mouse), representing the rostralmost part of the early involuting
mesoderm with self-organizing and inductive properties (Stern et al., 2001).
Recent evidence indicate that neural induction starts even before gastrulation
during which the hypoblast (in chick) or the anterior visceral endoderm (AVE)
in mouse induces the earliest neural fate (pre-neural stage) with anterior
characteristics (pre-forebrain). Thus, it is assumed that during gastrulation
inhibition of BMP signaling between ectodermal cells stabilizes and maintains
the neural induction (Fig.2; Stern et al., 2001,). According to the
activation/transformation model, the fate of the initially generated neural tube
with anterior characteristics is transformed into posterior neural fate as a
result of inductive interactions with the lately involuting mesoderm. Secreted
factors belonging to the Wnt, FGF and RA (retinoic acid) pathways are
involved in this process (Kudoh et al., 2002).  As a result, the AP axis of the
embryo body including CNS is established.
The development of the CNS depends on the spatiotemporal
expression of sets of genes. In the hindbrain, the proliferative NE is
subdivided into transverse segment territories (called rhombomeres) with
distinct molecular properties and identities (Kiecker & Lumsden, 2005). In
Drosophila, mouse and man the restricted expression of homeobox-
containing homeotic genes (Hox genes) along the AP axis of the body (in the
vertebrae, mesoderm, and CNS) generate the so-called HOX-Code that
defines the functional identity of corresponding domains of the body (Kessel
and Gruss, 1991; Krumlauf, 1992). Evidence from analysis of the expression
pattern of more that 100 transcription factors (most of which belonging to the
homeobox-containing genes) and regulatory molecules in the rostral brain
indicated that their expression domain, respect longitudinal and transverse
borders in the developing forebrain (Puelles & Rubenstein, 1993). This was
the basis for proposing the “prosomeric model” of forebrain organization,
according to which the prosomeres are transverse regions of the forebrain
neuroepithelium, molecularly specified by the expression of sets of
transcription factors (Fig.3; Rubenstein et al., 1994). The model was proven
Introduction
                                                                                                                            
10
and is widely used as a convenient morphological framework for the
interpretation of expression patterns in the developing CNS.
1.3. Neurogenesis in mammalian telencephalon
The generation of different neuronal types in the developing telencephalon
involves the coordinated programs of anterior-posterior (AP), dorso-ventral
(DV) patterning of progenitors in two proliferative zones, the ventricular (VZ)
and subventricular zone (SVZ) and their spatiotemporal specification.
Figure 4. Migration pathways of cortical interneuron subgroups orginating in
the ventral telecephalon
Schematic illustration shows distinct established (solid arrows) and possible (dashed
arrows) pathways of migration of cortical interneurons from subdivisions of the
ventral telecephalon to different places in the telecephalon. (Adapted from Wonders
& Anderson, 2006).
Based on the expression patterns of homeobox and other transcription
factors, the pallium is divided into four subdivisions: the medial, dorsal, lateral
and ventral palliums (MP, DP, LP, VP, respectively). The subpallium contains
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three main subdivisions: the lateral ganglionic eminence (LGE), subdivided
into the dorsal (dLGE) and ventral (vLGE), medial (MGE) and caudal
ganglionic eminences (CGE) (Fig.1; 4; Molnar et al., 2006; Puelles et al.,
2000; Marin & Rubenstein, 2001). In mouse, the domains of the pallium and
subpallium are specified by the differential expression of a number of
transcriptional factors in the proliferative NE already by the E8.5 (reviewed by
Rubenstein et al., 1994). While the progenitors of the dorsal telencephalon
generate a six-layered structure, in the ventral telencephalon they produce
several big nuclei. The main progeny of the pallial progenitors are the
projection pyramidal neurons, which are excitatory and glutamatergic. After
their generation in the ventricular zone (VZ), the neurons migrate radially
along the extended process of the RG cells to their final destination into
different cortical layers of the cortical plate (CP), a migratory process that is
accomplished only in the postnatal period (P7 in mouse).  In contrast, the
progenitors in the ventral telencephalon produce GABAergic interneurons and
stellate neurons of the basal ganglia. The interneurons (INs) migrate
tangentially to contribute to the formation of the distinct cortical layers  (Fig.4)
(Marin & Rubenstein, 2001; Gorski et al., 2002; Wonders & Anderson, 2006).
1.4. Neurogenesis in mammalian cortex
During development of the mammalian cortex, neurons and glia cells
(astrocytes and oligodendrocytes) are subsequently generated from neural
stem cells, thereby allowing the establishment of functional neural circuitry
(Bayer & Altman, 1991). In mouse cortex, neurons are generated largely from
embryonic day 10 (E10) to E17, astrocytes start to appear at around E16, with
their numbers peaking in the neonatal period, while differentiated
oligodendrocytes are first seen postnatally (Bayer & Altman, 1991). Cultured
E10–E12 cortical primary cells (considered as neural stem cells) generate
only neurons for the first few days, followed by the sequential genesis of
astrocytes and oligodendrocytes, indicating that an intrinsic program controls
the temporal cell differentiation of the cortical progenitors (Qian et al., 2000).
Studies in the last decade defined an intrinsic mechanism of epigenetic
status, transcription factors and an intrinsic influence of environmental cues in
establishing this fascinating and complex cell genesis, as well as the
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neurogenic-to-gliogenic switch in the developing cortex (reviewed by Miller &
Gauthier, 2007).
This introduction will focus mainly on the commitment of neural stem
cells to a neuronal fate and differentiation. Other steps of neurogenesis (from
neuronal maturation to synaptic integation of the newborn neurons in neuron
circuits) and gliogenesis are reviewed comprehensively elsewhere (Ming &
Song, 2005; Liedo et al., 2006, Ge et al., 2007; Miller & Gauthier, 2007).
1.4.1. Neural stem cells
In the mammalian telecephalon there are three different populations of
progenitors that generate neurons, namely the neuroepithelial (NE or stem
cells), radial glial (RG) and basal progenitor cells (BP, named also
intermediate progenitors, IP) (Fig.5). Before the beginning of neurogenesis,
NE forms a single layer of cells. The neural stem cells have the capacity of
self-renewal, which is achieved by symmetric or asymmetric cell divisions,
generating two daughter cells with stem cell properties, or one “renewed”
stem cell and a pluripotent (or partially fated progenitor), respectively
(Guillemot et al., 2006; Gotz & Huttner, 2005). The mechanisms involved in
self-renewal of neural stem cells, and maintenance of their undifferentiated
state is largely unknown. Findings in the last decade implicated a number of
signaling pathways like Notch, Fgf, Wnt and factors such as Emx2, REST,
Numb, Numb-like, Tlx, Bmi-1 is essetial in this process (reviewed by Alvarez-
Buylla & Lim et al., 2004).
At the onset of the neurogenesis, the NEs give rise to ealiest-borned
neurons of the cortex (the Cajal-Retziuz cells) and the RG cells (Fig.5). The
majority (more than 90%) of the cortical progenitors are RG cells expressing
immunoreactivity for RC2, Nestin, Vimentin, GFAP, astrocyte-specific
glutamare transporter (GLAST) and brain lipid binding protein (BLBP),
(Misson et al., 1988; Parnavelas & nadarajah, 2001; Campbell & Gotz, 2002).
Because shortly before birth the RG cells transform into astrocytes, the
classical view until recently was that the RG cells are progenitors of the glial
cell lineage only. Novel evidence, however, challenged this view. It turned out
that RG cells with long radial processes and expressing glial-specific markers
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Figure 5. The lineage trees show a simplified view of the relationship between
neuroepithelial cells (NE), radial glial cells (RG) and neurons (N), without (a) and with
(b) basal progenitors (BP) as cellular intermediates in the generation of neurons and
the types of cell division involved. (Adapted from Gotz & Huttner, 2005).
are actually pluripotent cortical progenitors that can generate both, neuronal
and glial cells. The RG cells divide at the apical surface of the telencephalic
vetricle and generate either directly or indirectly the majority of the cortical
neurons. In contrast to RG, the BPs undergo mitosis at the basal side of VZ,
where after stage E13.5 in mouse, a second proliferative zone is formed (the
subventricular zone, SVZ) (reviewed by Campbell & Gotz, 2002; Guillemot,
2005).
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1.4.2. Neuronal differentiation
In vertebrates, the transition of stem cells into committed neuronal progenitors
involves a highly coordinated switch in the transcriptional program. This
switch is regulated by basic helix-loop-helix (bHLH) transcriptional activators,
such as the proneural genes Ngn1 and Ngn2. The activation of proneural
genes has the capacity to initiate a full program for neuronal differentiation of
the neural stem cells (Ma et al., 1996; Farah et al., 2000; Mizuguchi et al.,
2001). Analysis of mouse null mutants revealed the determinant role of
proneural genes in the commitment of neural stem cells to a neuronal fate in
the cortical development (Fode et al., 2000; Nieto et al., 2001; Schuurmans et
al., 2004).  In single or double mouse mutants for Ngn1 and Ngn2, there are
severe defects in the neuronal differentiation program, including the
specification of the cortical neuronal layer identity and the acquisition of
proper transmitter phenotype (Fode et al., 2000; Schuurmans et al., 2004).
Interestingly, the reduced neurogenesis in the absence of function of these
proneural genes is accompanied by an increase in the gliogenesis,
demonstrating their importance in promoting the choice of a a neuronal fate
and inhibiting the alternative glia cell fate (Nieto et al., 2001; Sun et al., 2001).
Notably, the progression from neural stem cells to committed neuronal
progenitors and subsequent differentiation involves not only transcriptional
activators (like the proneural proteins) but also transcriptional repressors. In
fact REST/NRSF, a factor well known to repress neuronal genes in non-
neuronal cells was recently discovered as an important modulator of
neurogenesis (Ballas et al., 2005). This important study revealed that a
progressive reduction in the binding affinity of REST to neuronal promoters is
crucial for the transition from pluripotent stem cells to neural stem cells and
then to neurons. Strikingly Gage ´s laboratory identified a small modulatory
RNA (smRNA) with a similar binding sequence to REST/NRSF and which
acts as a competitor of REST/NRSF. Results from gain-of-function (GOF) and
dominant-negative experiments demonstrated the important role of this new
class of non-coding RNA in cell-lineage commitment and neurogenesis
(Kuwabara et al., 2004).
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1.4.3. Epigenetic factors in neurogenesis
It has also been demonstrated that the maintenance of pluripotetial stem cells
and their transition towards progenitors of different cell lineages such as
neurons and glial cells are also tightly controlled at a global level. These
studies provided evidence that chromatin-remodeling factors and modification
factors of the histone “code” are involved in switching on or switching off
genes in an “inactive” state in stem cells and an “active” state in differentiated
cells (Kaeser & Emerson, 2006). In fact, Xi & Xie, (2005) demonstrated that
distinct chromatin-remodelling complexes regulate the response to signals in
neurogenic zones that control the self-renewal of different stem cell types.
Recently, the examination of the role of Brg1, a catalytic subunit of SWI-SNF
involved in tissue-secific development, revealed that this chomatin
remodelling factor is required for neuronogenesis. Interestingly, interactions
between Brg1, Ngn and NeuroD implicate a coupling of chromatin remodeling
factors with neuronal commitment and neuronal differentiation factors in
regulating the neurogenesis (Seo et al., 2005a). Geminin, another factor with
high expression in neural progenitors, controls the progression from neural
proliferation to differentiation. Geminin was shown to interact with Brg1 and
antagonizes its function during neurogenesis (Seo et al., 2005b).
1.4.4. Adult neurogenesis
Neurogenesis was traditionally believed to occur only during embryonic
stages in the mammalian CNS (Ramon y Cajal, 1913). Only recently it
become generally accepted the existence of neural stem cells with limited
neurogenic capacity in few neurogenic zones of the mature brain, namely the
SVZ of the lateral ventricle and the subgranular layer (SGL) of the dentate
gyrus (DG) of hippocampus (Gross, 2000, Alvarez-Buylla & Lim et al., 2004;
Liedo et al., 2006). Understanding of adult mammalian neurogenesis has
considerable progress since one discoveries of the distribution of neural stem
cells, proliferation, specification of neuronal progenitors, neuronal maturation,
migration, nerve guidance, to synaptic integration of newborn neurons in the
adult neuron circuits (Gross, 2000, Alvarez-Buylla & Lim et al., 2004; Ming &
Song, 2005; Liedo et al., 2006). The common appearance of intrinsic and
external factors supporting neurogenesis in active zones of both the
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embryonic and adult brain suggest that there is (at least in part) a conserved
genetic program of neurogenesis in both stages of development (Hevner, et
al., 2006; Liedo et al., 2006). The main distinguishable feature of adult and
embryonic neuronogeneses is that in the adult brain, neurogenesis is taking
place in an environment that does not favor the generation of new neurons.
Therefore, neurogenesis in the adult forebrain needs a protection from the
anti-neurogenic influences of the surrounding environment and requires the
maintenance of permissive niches (Kempermann et al., 2004; Alvarez-Buylla
& Lim et al., 2004; Liedo et al., 2006). The demonstration of active adult
neurogenesis opens possibilities for repairing of the adult CNS after injury or
degenerative neurological diseases in the future.
1.5. Introduction of the mammalian cortical development
In the mammalian cortex, billion of neurons with distinct morphologies,
connectivities, molecular and physiological properties are organized radially in
six layers and in numerous tangential functional domains. The study of
corticogenesis before 1990 formulated two general hypotheses: the protomap
(Rakic, 1988) and protocortex (O´Leary, 1989). The former proposed that the
cortical progenitor zone contains the information that determines the cortical
areas identity, whereas the later theory postulated that thalamic afferent
axons impose the cortical area identity through activity-dependent
mechanism.Abundant recent evidence indicates, however that cortical
regionalization includes interplay of intrinsic as well as extrinsic mechanisms
(reviewed by Sur & Rubenstein, 2005). The intrinsic mechanisms seem to
have a more decisive role in the molecular patterning and establishment of
cortical area identity, while the thalamocortical projections contribute to the
final delineation and maintenance of the area size  (O´Leary, 1989; O´Leary
and Nakagawa, 2002; Sur & Rubenstein, 2005).
 The neurons of distinct cortical layers are generated according to an
inside-first/outside-last program. In this way, the early-born neurons (during
the period E10-E14 in mouse) populate the lower layers 6 and 5 (L6, L5,
Introduction
                                                                                                                            
17
Figure 6. Schema showing the three progressive stages of corticogenesis:
preplate formation, lower and upper layer formation
The formation of the preplate (PP) requires the expression of Tbr1, whereas the
generation of Cajal-Retzius (CR) neurons (brown cells) involves the suppression of
Foxg1 at the earliest stages of corticogenesis. Deep layer neurons (light blue cells)
are generated and require the function of both Ngns (for L6, L5) and Tbr1 (for L6).
When upper layer cortical neurons (L4-2, red cells) are generated, Ngns and Tbr1
appear to be dispensable, but the functions of Pax6 and Tlx are absolutely required.
II-VI, layer 2-6; IZ, intermediate zone; MZ, marginal zone; PP, pre-plate; SP,
subplate; SVZ, subventricular zone; VZ, ventricular zone;  (Adapted from Campbell,
2005).
named also infragranular layers, IGLs). The neurons generated by the late
progenitors (E14.5 – E18.5) form the upper layer (L4, L3, L2, also named
supragranular layers, SGLs) (Rakic, 1988). Results form classical
transplantation experiments in ferret revealed that the acquiry of distinct
neuronal layer fate is dependent on environmental cues after the S phase of
the last mitotic cycle of the progenitors (McConnell & Kaznowski, 1991).
Furthermore recent data indicates that specification of layer identity in the
cortical neurons depends on the function of different transcription factors
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during, a specific developmental time window. For instance, telencephalic
transcription factor Foxg1 is required to suppresse the earliest born
neurons, the Cajal-Retzius (CR) cells and thereby restricts the
developmental potential of cortical progenitors (Hanashima et al., 2004). In
addition to Foxg1, T-box transcription factor (Tbr1) has been shown to be a
genetic determinant for preplate formation, including the differentiation of
early-born glutamatergic neurons, CR cells (Fig.6, Hevner et al., 2001;
Cambpell, 2005; O´Leary and Nakagawa, 2002).
1.6. Transcription factor Pax6
1.6.1. Conserved function of Pax6 in evolution
Pax6 is a member of the evolutionary conserved Pax gene family (reviewed
by Callaerts et al., 1997; Mansouri et al., 1999; Simpson & Price, 2002;
Kozmik, 2005). Pax6 was first cloned from human and subsequently from
other vertebrate and invertebrate species (reviewed by Callaerts et al., 1997).
Pax6 orthologues are highly conserved in both their protein sequence and
function. Therefore it is likely that the downstream targets of Pax6 are also
highly conserved among species (reviewed by Gehring & Ikeo, 1999).
Mutation of Pax6 in humans causes the inherited disease aniridia
(Heyman et al., 1999; Malandrini et al., 2001; Sisodiya et al., 2001),
characterized by multiple ocular defects and some neurological and
behavioral disabilities (e.g. deficiency in learning). A point mutation between
PD and HD of Pax6 leads to the generation of a premature stop codon and
therefore to premature termination of the translation, thus producing a protein
without any functional activity (Hill et al., 1991). The homozygous Sey/Sey
mice die at birth without eyes and severe brain abnormalities (see below).
Heterozygous mice show defects in the optic cup (Hill et al., 1991).
Of the four Drosophila Pax6 orthologues, it is thought that the
eyeless (ey) and twin of eyeless (toy) gene products share functional
homology with the vertebrate canonical Pax6 isoform. Two other Drosophila
Pax6 orthologues, Eye gone (Eyg) and Twin of Eyegone (Toe), lack the
amino-terminal PAI domain and rely only on the RED and HD domain for their
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binding capacity. The sequence specificity of Eyg has been studied and found
to be very similar to that of Pax6(5a) (Jun et al., 1998; Kozmik, 2005).
Similarly, homologue Pax6 mutant, ey in the Drosophila shows ocular defects
analogous to those found in humans and mice (Quiring et al., 1994). By
targeted expression of the ey, toy, mouse or human Pax6 in various imaginal
disc primordia of Drosophila, ectopic eye structures were induced on the
wings, the legs, and on the antennae (Czerny et al., 1999; Halder et al.,
1995). Reciprocally, vertebrate eye-like structures can be generated by the
ectopic expression of ey or toy in Xenopus (Onuma et al., 2002). These data
demonstrate that the function of Pax6 is conserved during eye development in
animal phyla (reviewed Gehring & Ikeo, 1999; Gehring, 2002).
In addition to its role in eye genesis, Pax6 is also important in
development of the brain and olfactory organs. The Sey/Sey embryos lack
nasal structures and die at birth with serious brain abnormalities, including
forebrain patterning and growth defects. Aniridia patients, heterozygous for
mutations of Pax6, also show defects in cerebral cortex and olfactory organs
(Sisodiya et al., 2001, see below). The drosophila Pax6 homologues ey and
toy are also expressed in the central nervous system, particularly in the
mushroom bodies (Callaerts et al., 2001; Kurusu et al., 2000), which are
higher-order brain centers for olfaction associated with learning and
elementary cognitive functions in the fly (reviewed by Heisenberg, 1998). Ey
has been shown to have an important function during axonal differentiation of
neurons in the mushroom bodies (Callaerts et al., 2001; Kurusu et al., 2000).
Evidence has been also presented for the evolutionary conservation of
Pax6 gene regulatory elements. Tp date multiple distinct promoters and
regulatory elements of mouse Pax6 have been identified (Kammandel et al.,
1999; Anderson et a., 2002; Griffin et al., 2002; Morgan, 2004; Kleinjan et al.,
2004; Kim & Lauderdale, 2006). Kammandel et al (1999) reported the
identification of three conserved transcription start sites (P0, P1, alpha) in the
murine Pax6 locus. By using transgenic mouse, independent cis-regulatory
elements controlling the tissue-specific expression of Pax6 were defined.
Specifically, the 4.6-kb region upstream of exon 0 is required to mediate Pax6
expression in the lens, cornea, lacrimal gland and pancreas. Another 530-bp
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enhancer fragment located downstream of the Pax6 translational start site in
exon 0 is required for expression in the neural retina, the pigment layer of the
retina and the iris. Finally, a 5-kb fragment located between the promoters P0
and P1 can mediate expression in the dorsal telencephalon, hindbrain, and
the spinal cord (Kammandel et al., 1999). Interestingly, an enhancer of
Drosophila ey inserted in front of either P0 or P1, is able to reproduce features
of the endogenous expression pattern of mouse Pax6 in transgenic mice (Xu
et al., 1999). In a reciprocal experiment, the mouse P1 element is also able to
drive lacZ reporter gene expression in the eye of Drosophila (Xu et al., 1999).
This further suggests that Pax6 is preserved during evolution not only at the
nucleotide level but also at the functional level.
1.6.2. Pax6 in the mammalian forebrain
In the developing mouse brain, the expression of Pax6 is detected as early as
E8.5, confined to the progenitors in the VZ of the dorsal telencephalon, the
anlage of the cortex (Walther and Gruss, 1991; Stoykova and Gruss, 1994).
The majority (88%) of the E13.5 cortical progenitors represent the RC2-
positive radial glial progenitors that also express Pax6 (Gotz et al., 1998). In
absence of Pax6, the RG progenitors have morphological defects and
abnormalities in their mitotic cycle and expression patterns, indicating that
Pax6 is an intrinsic determinant of RG progenitors (Gotz et al., 1998).
1.6.2.1 Pax6 in the regional patterning of the forebrain
Studies on the function of Pax6 last decade demonstrated an essential role of
Pax6 in the patterning of the telecephalon. The expression of Pax6 and the
homeobox transcription factor Gsh2 is restricted to the progenitors of the
pallium and subpallium, respectively, governing cortical and striatal
development by regulating genetically opposing programs (reviewed by
Guillemot et al., 2006). In the Sey/Sey mutant mice where Pax6 is not
functional (Hill et al., 1991), there is a severe defect in dorsoventral (D/V)
molecular patterning at the pallial-subpallial border (PSPB), seen as a down-
regulation of the expression of pallial markers and a shifting of the expression
of ventral molecular markers into more dorsal pallial domains (Stoykova et al.,
1996; 2000;Toresson et al., 2000; Yun et al., 2001; Muzio et al., 2002; Kroll
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and O´Leary, 2005). As a result of the progressive ventralization of patterning
at the PSPB, during development a portion of the pallial progenitors acquire
subpallial identity that leads to increase of ectopically located GABAergic INs
in the pallium (Kroll and O´Leary, 2005).
In the cortical progenitors, the expression of Pax6 shows a gradient,
being strongly expressed rostrolaterally and only faintly in the caudomedial
domains. In contrast, the homeobox transcription factor Emx2 exerts a
complimentary gradient in developing cortex, expressed at a high level in
caudomedial and at low level in the rostrolateral cortex. By comparing the
expression patterns of molecular markers in these two mutants, opposite
defects in cortical arealization were detected, suggesting that Pax6 and Emx2
might be able to regulate their own specific expression profiles that have a
role in specification of the rostral or caudal cortical identity, respectively
(Bishop et al., 2001, 2002, Muzio et al., 2002; reviewed by Mallamaci,
Stoykova, 2006). Notably, in absence of the function of both Emx2 and Pax6
proteins, the entire cortex acquires morphological and molecular features
reminiscent of those of the striatum (Muzio et al., 2002a; Muzio et al., 2002b).
It should be noted however that due to severe defects in the diencephalons
found in the Sey/Sey embryos  (Stoykova et al., 1996; Warren and Price,
1997), the thalamocortical axons do not reach the cortex (Jones et al., 2002).
This limits the analysis of effect of the abolishment of the Pax6 function on the
cortical area identity, normally throught studying the axonal projections
between distinct cortical areas and their corresponding target s within sensory
nuclei of the diencephalon. Thus function of Pax6 in the cortical identity is still
remaining to be investigated.
1.6.2.2 Pax6 in neuronal specification and cortical layers
As already noted Pax6 is expressed in the radial glial cells (RG), a majority of
the dorsal pallium progenitors generating both neurons and glial cells
(Malatesta et al., 2000; 2003; Miyata et al., 2001; Anthony et al., 2004; Noctor
et al., 2004). In the Sey/Sey mutant mice the cortical RG progenitors show
alterations of their morphologies, proliferation parameters and expression
patterns (Götz et al., 1998; Warren et al., 1999; Estivill-Torrus et al., 2002)
and they generate no more than 50% of the normal neuronal progeny of the
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cortex  (Malatesta et al., 2000).  Recent results from retrovirus-mediated
overexpression of Pax6 in cortical primary cultures demonstrated an
enhancement of the neurogenesis in primary cortical cultures in vitro  (Heins
et al., 2002). Similarly, conditional overexpression of Pax6 in the cortical
progenitors of transgenic mice in vivo indicated a limited enhancement of
neurogenesis especially by the progenitors in the ventral pallium (Berger et
al., 2007). Together, these data indicate that the expression of Pax6 in cortical
progenitors endows them with neuronal ability (Heins et al., 2002).
Analysing the cortical phenotype of Sey/Sey embryos revealed severe
defects in neuron generation especially of the upper cortical layers, which
might be involved in migratory deficits of the SGL neurons (Caric et al., 1997).
The expression of the specific markers, Svet1, Cux1/2 and Satb2, both in the
pallial progenitors of the subventricular zone (SVZ) and in the upper layers, is
abolished in the Sey/Sey cortex (Tarabykin et al., 2001, Nieto et al., 2004;
Britannova et al., 2005), suggesting a Pax6-dependent mechanism for
generating the upper cortical layers mediated by the progenitors located in the
SVZ (reviewed by Cambpell, 2005; Guillemot et al., 2006). Recently analyses
of mutants for cortical layer determinants suggested the idea that the
generation of the lower and upper cortical layers is controlled largely by the
Ngn1/2-dependent and Pax6-depentdent mechanisms, respectively (Fig.6,
Cambpell, 2005, Shuurman et al., 2004).
However, because Sey/Sey  embryos die at birth while the final
neuronal allocation in distinct cortical layers is accomplished only postnatally.
Therefore the final conclusion about the layering defects in the Sey/Sey
mutant is still an open question.
1.6.3. Molecular properties of the Pax6 protein
In vertebrates the Pax6 gene encodes two protein isoforms, Pax6 and
Pax6(5a) (Fig.7; Carriere et al., 1995; Richardson et al., 1995; Zaniolo et al.,
2004). Knowledge about the molecular structure of Pax6 proteins is critical to
their biological activity. The paired domain (PD) can be structurally and
functionally separated into two independent DNA-binding sub-domains, PAI
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Figure 7. Structure and DNA-binding domains of Pax6
(A/B) In vertebrates Pax6 genes encode two Pax6 isoforms, Pax6 (A) and Pax6(5a)
(B) with two different DNA-binding domain, PD and HD. PD can be structurally and
functionally separated into two DNA-binding subdomains, PAI and RED. Analyses of
mouse Pax6 mutants with defects either in PD or HD showed that the PD of Pax6 is
important for the regulation of neurogenesis, proliferation and regionalization in the
developing telencephalon, while both PD and HD are required for the formation of
the pallio-subpallial boundary (A). Retroviral overexpression revealed the anti-
Introduction
                                                                                                                            
24
proliferative role of the Pax6(5a) isoform in cortical cells (B). (C) Distinct domains of
Pax6 and Pax6(a) can bind specifically to DNA sequences. Transactivation domain
(TA) is required for the full activity of Pax6. PD, Paired Domain; HD, Homeobox
Domain; TA, Transactivation Domain; P6CON, Consensus Pax6 Binding Site;
5aCON, Consensus Pax6(5a) Binding Site; HDCON, Consensus Binding Site of
Pax6 HD (Adapt from Haubst et a., 2004).
and RED (Fig.7; Czerny et al., 1995; Epstein et al., 1994b; Jun et al., 1998).
Mouse Pax6 contains 128 amino acids (Epstein et al., 1994a). In contrast,
Pax6(5a) contains a 14 amino acid insertion within the PAI domain forming a
distinct paired domain, PD-5a. This insertion eliminates the DNA-binding
capacity of the PAI subdomain, leaving the RED subdomain and HD
responsible for DNA recognition.
Consequently, these two Pax6 variants recognize different DNA
sequences (Fig.7; Epstein et al., 1994b; Kozmik et al., 1997). This initial study
showed that the Pax6-binding sequence (known as P6CON) is a bipartite
region of 20 base pairs with its 5'-half and 3'-half recognized by the PAI and
RED sub-domains, respectively (Fig.7; Epstein et al., 1994a; Czerny et al.,
1995). P6CON was derived as a perfect binding site deduced from a series of
enrichments for high affinity binding oligonucleotides from an initial pool of
random oligonucleotides (Epstein et al., 1994a). Similarly, perfect binding
sites were identified for PD(5a) and HD, called 5aCON and HDCON (Fig.7),
respectively (Epstein et al., 1994b; Czerny et al., 1995). Evidence for
cooperation between Pax6 PD and HD has been shown in the promoter of the
neural cell adhesion molecule L1 (Chalepakis et al., 1994). Thus, the
DNA–binding properties of the functional Pax6 domains implies that distinct
Pax6 binding domains, alone or in cooperation, could regulate different
classes of downstream target genes. In fact, a recent analysis of several
mouse Pax6 mutants with distinct defects either in PD or HD, combined with
gain-of function studies, demonstrated that while the Pax6 PD is necessary
for regulation of Pax6-dependent neurogenesis, cell proliferation and
patterning, both PD and HD are required for boundary formation at the PSPB.
Furthermore retrovirus-mediated overexpression of the Pax6(5a) isoform
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inhibits cell proliferation without affecting cell fate. Therefore these results
demonstrate a key role for the functional domains of Pax6 in different features
of brain development (Fig.7; Haubst et a., 2004).
Molecular studies have also shown that the entire C-terminal region of
Pax6 is an activation domain, essential for full activity of the protein (Glaser et
al., 1994; Tang et al., 1998; Singh et al., 1998; Duncan et al., 2000a; Mikkola
et al., 2001). This activation domain is phosphorylated by kinases, including
ERK, p38 kinases and HIPK2 (Carriere et al., 1993; Mikkola et al., 1999;
2001; Kim et al., 2006). The principal residue, serine 413, is evolutionary
conserved. If this serine is mutated to alanine, the transcriptional activity of
Pax6 is significantly reduced (Mikkola et al., 2001). O-glycosylation of Pax6
was reported (Lefebrve et al., 2002) that might modulate protein-protein
interaction between Pax6 and other proteins. Future studies about
posttranslational modifications of Pax6 might elucidate further the function of
Pax6 in development.
1.6.4. Targets of Pax6 in development
Genes whose expression are modulated by direct interactions between
transcriptional factors and their regulatory elements, referred to direct targets.
Identification of genes regulated by Pax6 is an essential issue in
understanding its biological function.  T o  s h o w  t h e  m o l e c u l a r  m e c h a n i s ms  o f 
P a x 6 -d e p e n d e n t  g e n e  regulation ,  t h e  d a t a  h a v e  t o  p a s s  a  s e r i e s  o f  t e s t s 
( Chalepakis  et  a l . ,  1 9 9 2 ) .  T h e  expression pattern  o f  t h e  P a x 6  p r o t e i n  h a s  t o 
p r e c e d e  a n d  o v e r l a p  t h e  e x p r e s s i o n  p a t t e r n  o f  t h e  m R N A  o f  i t s  t a r g e t  g e n e .
The expression level of the target gene must be modulated in response to the
activation and inactivation of Pax6 in vivo.  R e g u l a t o r y  r e g i o n s  o f  t a r g e t  g e n e s 
h a v e  t o  c o n t a i n  a t  l e a s t  o n e  P a x 6  b i n d i n g  s i t e .  B i n d i n g  o f  P a x 6  t o  t h i s  r e g i o n 
h a s  furthermore t o  b e  d e m o n s t r a t e d  b o t h  i n  v i t r o  u s i n g  f o o t p r i n t i n g  or g e l  s h i f t 
a s s a y s  a n d  i n  v i v o  u s i n g  c h r o m a t i n  i m m u n o p r e c i p i t a t i o n s  ( C h I P s ) .  Trans-
activation assays of the re g u l a t o r y  r e g i o n s with a r e p o r t e r  g e n e (e.g.
luciferase, LacZ, or GFP) in  cell culture  ,  in ovo experiment or  in vivo
transgenic  mice , give the final proven that activation of a candidate gene is
under direct control of Pax6.
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Studies have revealed that Pax6 regulates a diverse range of genes
(reviewed by Simpson and Price, 2002), including transcription factors: Ngn2,
Six3, c-Maf, Prox1, Brg1, Pitx3 and Etv6 (Scardigli et al., 2003; A s h e r y - P a d a n 
e t  a l . ,  2 0 0 0 ;  G o u d r e a u  e t  a l . ,  2 0 0 2 ;  S a k a i  e t  a l . ,  2 0 0 1; C h a u h a n  e t  a l . ,  2 0 0 2)
and specific adhesive molecules: Integrins, R-cadherin and L1-CAM ( D u n c a n 
et a l.,  2000b ; Andrews and Mastick, 2003).
Recently new methods that utilize high throughput techniques such as
cDNA microassay ( C h a u h a n  e t  a l . ,  2 0 0 2 ; Holm et al., 2007 )  and chromatin
immunoprecipitation on chip ( C h I P -on chip ;  W e i n m a n n  a n d  F a r n h a m ,  2 0 0 2 ) 
are speeding up the identification of downstream genes of Pax6.  
1.7. Post-translation modification and ubiquitination of
protein
The proteins that underlie the behaviour of any cell type are produced by
selective gene expression. However, cells respond continuously to cues from
their external and internal environments. The cellular response to changing
conditions is frequently mediated by numerous post-translational
modifications (PTMs) of the proteins, including phosphorylation, ubiquitination,
sumosylation, methylation, acetylation or glycosylation (see review by Walsh
& Jefferis, 2006). PTMs are chemical modifications of proteins, one of the
later steps in the protein biosynthesis for many proteins. A crucial point for
understanding the cellular regulation of PTMs is to define mechanisms by
which they exert alterations in cellular phenotype. One mechanism by which
PTMs can alter the function of protein is to directly induce a new
conformational state. Thus, if PTMs occur with proteins that act as regulatory
determinants, this might cause changes in the cellular phenotypes of those
proteins  (Walsh & Jefferis, 2006). Alternatively, PTMs could modify histon
proteins or chromatin remodeling factors. In this way PTMs could modulate
either the transcription machinery at a global level or the cell lineage-specific
expression of genes (Li et al., 2007)
Among PTMs, protein ubiquitination mediates various mechanisms in
control of the protein activity. Initially protein ubiquitination is though to have
an exclusive function in labeling the target protein for the ubiquitin-
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proteasome system (UPS)-mediated degradation. In this mechanism,
ubiquitination is a sequence of reactions catalyzed by at least three classes of
enzymes. Ubiquitin is first activated by the ubiqutin-activating enzymes (E1),
delivered to the ubiquitin-conjugating enzymes (E2), and then transferred to or
mediated by the ubiquitin ligases (E3). Among these, the E3 ligase defines
the specificity of substrates (Hochstrasser, 2006). The E3 ligases are
categorized into three distinct classes based on the domain with E3 ligase
activity: HECT, U-box and RING finger-containing E3 ligases. During protein
ubiquitination, RING finger-containing E3 ligases interact with both E2
enzymes and substrates to bring them into a close proximity, allowing the
transfer of the ubiquitin moiety from E2 enzymes to substrates (Hochstrasser,
2006). However recent studies reported that protein ubiqutination is also
involved in controlling the epigenetic, gene–silencing and transcriptional
programs (Li et al., 2007). Future studies are necessary to understand
additional PTMs, their mechanisms and the protein targets of PTMs during
different cellular responds.
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1.8. The aims of study
Our understanding of Pax6 function in the mammalian corticogenesis relied
so far largely on analysing the phenotype of mice with the natural mutation of
Pax6 in the Sey mice or in mice after a conventional knockout of Pax6
(Pax6KO mice) (St-Onge et al., 1997; Hill et al., 1997). However both of these
Pax6 deficient mice in homozygosity die at birth, thus making impossible to
study cortical layering, because the allocation of cortical neurons in their final
positions in the distinct cortical layers is accomplished only during the second
postnatal week (in mouse). The analysis of the role of pax6 in cortical area
identity is also not possible because of severe defects of the sensory
thalamus. The main aim of this project was to use the Cre-LoxP
recombinantion system in order to generate a cortex-specific knock out of the
Pax6 function only in the pallial progenitors at the beginning of the
neurogenesis thus possibly allowing to avoid the lethality of embryos of the
Pax6 mutant. With this system one expects to gain understandings of the role
of Pax6 in different aspects of the postnatal cortex. Given that the determinant
role of Pax6 in the corticogenesis, the second aim of this study was to search
for cofactors that modulate the neurogenic activity of Pax6.
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2. Results
2.1. Transgenic system for the conditional inactivation
of Pax6 in cortical progenitor
Figure 8. The targeted inactivation of Pax6 in cortical progenitors
(A) The schema represents the relative positions of exons, loxP sites and primers for
genotyping in WT allele (Pax6+ allele), floxed Pax6 allele (Pax6fl/fl allele) and Cre-
mediated deletion of floxed Pax6 allele (Pax6del allele) (Ashery-Padan et al., 2000).
(B) Combinations of primers with sizes of PCR products for genotyping of embryos
and mice in the targeted inactivation system of Pax6 in cortical progenitors are
indicated. The quantification by WB (B) and qPCR (C) showed a diminishing at
protein and RNA level of Pax6cKO as compared to the control. (D) The comparison
revealed Pax6cKO mice have a smaller brain at both P14 and adult than those of
WT. qPCR, Quantitative RT-PCR; WB, Western blot.
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In order to perform inactivation of Pax6 only in the cortical progenitors, we
applied the Cre-LoxP recombination strategy (Sauer & Henderson, 1989;
Rajewsky et al., 1996; reviewed by Kwan, 2002). This technique has proved
to be a very useful tool for activation and inactivation of specific genes in a
“conditional” manner in spatially and temporally restricted patterns. This helps
to circumvent the limitations of conventional gene inactivation, particularly,
when a given gene has multiple roles at different times and in different
tissues. The Cre-LoxP systems consist of two basic elements (two transgenic
mouse lines). One line carries the conditional allele, in which a gene segment
(or the entire gene) is flanked by the two recognition target sites (loxP). LoxP,
a 34-bp consensus sequence, consists of two 13-bp inverted repeats, flanking
an 8-bp non-palindromic core. Another transgenic line provides a spatially and
temporally controlled expression of the recombinase enzyme (Cre). The Cre
recombinase catalyzes recombination to bring about the deletion of the
associated DNA in between the two LoxP sites (Sauer & Henderson, 1989;
Rajewsky et al., 1996; reviewed by Kwan, 2002).
In this study, we used two transgenic mouse lines: Pax6 flox mice
(Ashery-Padan et al., 2000) and Emx1 IRES-Cre mice (Gorsky et al., 2002). In
the Pax6flox mice the wild type (wt) allele (Pax6+ allele) is replaced by gene
targeting with a modified Pax6 allele (Pax6 flox allele), in which the partial exon
4 and exons 5, 6 (covering the paired domain), are flanked by two loxP sites
(Fig.6A; Ashery-Padan et al., 2000).  In the Emx1IRES-Cre mice, the expression
of Cre recombinase is controlled by the promoter of the gene Emx1, thus
being active only in the pallial progenitors, driving effective recombination
strating at stage E9.5, and reaching full recombination at stage E12.5 (Gorski
et al., 2001). Thus by crossing the Pax6 flox and Emx1 IRES-Cre mice, we
generated a double transgenic mouse line in which the function of Pax6 is
conditionally inactivated only in the pallial progenitors at the onset of
neurogenesis. The system for the cortex–specific inactivation of Pax6 was
verified by using set of primer pairs for the genotyping allowing to identify the
floxed (400bp), wild type (WT, 300bp) or the deletion (700bp) fragment of the
corresponding alleles (Fig.8A/B). The western blot and qPCR analyses of
extracted proteins and RNA from E12.5 cortices furthermore revealed no
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more that 8% residual level of Pax6, both at protein and RNA level, in the
Pax6fl/fl; Emx1IRES-Cre pallium (named thereafter Pax6cKO) (Fig.8B/C). The
generated Pax6cKO mice are healthy, fertile, and reach adulthood. The only
obvious malformation of the isolated Pax6cKO brain was its smaller size as
compared to WT at both juvenile (P10-P15) and adult (3-7 months old) stage
(Fig.8D).
2.2. Pax6 specifies the upper cortical layer neurons
Previous data suggested that in the Sey/Sey embryos the upper cortical
layers are misbuilded (Schmahl et al., 1993; Caric et al., 1997; Stoykova et
al., 2000, Schuurman et al., 2004). Two mechanisms have been proposed to
be involved in this defect: either a failure in specification of the upper layer
neuronal fate (Tarabykin et al., 2001; Schuurmans et al., 2004) or migratory
deficiency specifically affecting the late-born neurons (Caric et al., 1997). As
already mentioned, the early prenatal lethality of the Sey/Sey embryos
seriously hampers the study of these processes, because cortical neurons
reach their final location into the CP not earlier than stage P8 in mouse.
We took advantage of the Pax6cKO mice to examine this issue. We
studied the specification of the SGL neurons at postnatal stage P10 (when the
neurons are already located at their final position) by using different molecular
markers such as Cux2 (for L4-2; Iulianella et al., 2003), EphA4 (for L4-2,
Garel et al., 2002), RZRß  (for L4; Nakagawa & O'Leary, 2003), Svet1
(Tarabykin et al., 2001), Lmo4 (mostly L4-2, Bulchand et al., 2003). The
results showed that Cux2+ neurons were entirely missing in the rostroparietal
mutant CP (Fig.9A/A´) as well as in progenitors of SVZ at E16.5 (data not
shown). Only a few CP cells in the mutant expressed Eph4 (Fig.9B/B´), RZRß
(Fig.9C/C´), and Svet1 (Fig.9F/F´). Similarly, the expression of Lmo4 was
down regulated in the SGLs of the mutant frontal cortex (Fig.9D/D´).
Interestingly, transcription factor Id2, normally expressed in the neurons of L5
as well as in the SGL neurons (Neuman et al., 1993; Jen et al., 1997) was
specifically down regulated only in the upper
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Figure 9. Pax6 specifies the upper cortical layers neurons
ISH and IHC on sections from E16.5 brains (G/G´, I/I´) and from P10 (the others) with
markers as indicated. The results showed a complete loss in the expression of Cux2
(A/A´) or severe attenuation in expression of EphA4, RZRß, Lmo4 (B/D´, pointed with
arrowheads). Note that the expression of Lmo4 in SGL is lost in the rostral cortex,
however a thicker band is seen in the position of the IGL neurons (arrow, D/D´).
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(G/H´) Id2 expression is not seen in the rostral SGL neurons at P10, while at E16.5,
big expression gaps were detected. (I/J´) Similarly, such complete loss in rostral SGL
neurons at P10 and expression gaps at E16.5 was observed in the expression of
Lhx2 in Pax6 mutants as compared to the control. (E/E´) Immunostaining with neuN
antibody revealed only a few neurons in the position of the SGLs. After BrdU
birthdating at stage E16.5 (K/K´) and E18.5 (L/L´), BrdU+ cells are missing at SGL
and kept in excess in GE of the Pax6cKO cortex at P10 (K/L´). GE, Germinative
epithelium; SGL, Subgranular layer.
cortical layers of the rostral cortex (Fig.9H/H´). Analysis of the expression of
Id2 at stage E16.5 (when the generation of the upper layer neurons is at
maximum) showed big expression gaps rostrally (Fig.9G/G´) suggesting that
proportion of these progenitors are not specified towards the Id2+ neuronal
fate in absence of Pax6. Likewise, the strong expression of TF Lhx2 in the
superficial L4-2 at P10 (Bulchand et al., 2003) was abrogated in the mutant
(Fig.9J/J´) at P10. Interestingly, similarly to Id2, also the expression of Lhx2 at
E16.5 exhibited big expression gaps in the progenitors of the rostral cortex
(Fig.9I/I´), suggesting a failure of the specification of this neuronal sub-lineage
as well. In addition and consistent with the results from the in situ
hybridization analysis, immunostaining with NeuN, a marker for postmitotic
neurons revealed only few neurons at the position of the SGLs in Pax6cKO
brains (Fig.9E/E´).
To study whether the lack of SGL neurons at their normal location
might be a result of migratory problems, we traced the SGL neurons in the
postnatal Pax6cKO cortex by BrdU-pulse labeling at E16.5 (when the
generation of SGL peaks) and at E18.5 (when predominantly L3-2 are born).
We noticed a severe depletion of BrdU+ cells in the SGLs in both stages
along with an increased number of BrdU+ cells in the GE at the PSPB
(Fig.9K/L´). The migration defect hypothesis implies that SGL cells were
specified correctly, but remain near their origin in the GE. However, despite
using numerous SGL markers, we were unable to detect any correctly
differentiated SGL neurons either in ectopic lower positions of the CP or in the
enlarged VZ/SVZ of the Pax6cKO cortex at P10 or 3 months after birth.
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Together these, results indicate that late RG progenitors in the Pax6cKO do
not transition into distinct SGL neuronal subpopulations in a region-specific
manner and furthermore indicates that Pax6 has an intrinsic role in the
specification of the upper cortical layer neurons.
2.3. The lack of Pax6 affects normal neuronal outcome and
the migration of subpopulations of IGL neurons
Recent data from mutant analyses supports the view that different genetic
mechanisms are involved in the cortical layer specification in which the
generation of IGL is largely dependent on the function of Ngn1/2, while the
production of the SGL appears to depend on Pax6 and Tlx function  (Fig.6;
Schuurmans et al., 2004, reviewed by Campbell, 2005). However, during
development Pax6 shows strong expression in the early RG progenitors
(generating the IGL neurons) and Pax6 directly controls the expression of
Ngn2, especially in the rostrolateral pallium (Stoykova et al., 2000; Scardigli
et al., 2003). This motivated us to reexamine the question whether Pax6 might
be involved in the patterning of the IGL neurons.
Initial results from immunohistochemistry with NSE (neuron specific
enolase) antibody strongly suggested that the number of the pyramidal
neurons in the Pax6cKO cortex was enhanced, and NSE+ cells appeared
trapped within corpus callosum (CC) above the hippocampus (Hi, Fig.10C/C´).
In addition, the Pax6cKO cortex showed an intensified immunoreactivity for
SMI-32 antibody that predominantly labels large pyramidal neurons of layer 5
(L5, Voelker et al., 2004) at P10 (Fig.10E/E´) and in the adult brain
(Fig14D/D´).
To assess IGL neuronal identities of the pyramidal neurons from
distinct layers, we performed in situ hybridization analyses with layer specific
probes on sections from Pax6cKO and control mice at P10. The gene Vglut1
(vesicular glutamate transporter 1) is expressed in all pallial glutamatergic
neurons, most strongly in L5 pyramidal neurons (Fremeau et al., 2000). In the
mutant, the darker stained band of such neurons was displaced to the
uppermost position of the CP and Vglut1+ cells were stranded in the lowest
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Figure 10. Defects in the migration and pool-size of subsets of IGL neurons of
Pax6cKO cortex
ISH and IHC analyses revealed defects in the migratory properties of subpopulations
of IGL neurons, labeled by NSE (C/C´), Vglut1 (D/D´), Lmo3 (I/I´´), Lmo4 (J/J´´), Fezl
(K/K´´), Clim1a (L/L´´), Slap1 (data not shown). In the mutant, an augmented pool of
subsets of IGL neurons, expressing NSE (C/C´), Smi-32 (E/E´), Fezl (K/K´´), Clim1a
(L/L´), also Lmo4 (Fig.9D/D´) was detected. Arrows point to ectopic mis-locations of
cell populations in the mutant cortex. After BrdU labeling at E16.5, the double
IHC/ISH analysis with BrdU antibody and ISH markers for L5 neurons, Clim1a (G) or
Fezl (H) showed no co-localization of BrdU with these two markers.  No change in
the expression pattern of two other IGL markers for L6, Tbr1 (A/A´), Nurr1 (B/B´) was
found in the mutant cortex. GE, Germinative epithelium; OB, ofactory buld;
portion of the CP as well as in the enlarged rostral GE (Fig.10D/D´). Similar
cell aggregates were also observed along the CC, hippocampal SVZ (HiSVZ),
and posterior periventricular zone (pPv; data not shown). However, the
expression of transcription factors Tbr1 in L6 (Fig.10A/A´) and Nurr1 in L6a
(Fig.10B/B´) appeared not affected in the mutant. The two members of the
LIM-only gene family Lmo3 and Lmo4 are expressed in subsets of IGL and
SGL neurons (Bulchand et al., 2003). The broad and faint expression zone of
Lmo3 that includes most of L5 and L6a neurons was displaced to a more
superficial position in the mutant CP (Fig.10I/I´), while rostromedially, Lmo3+
cells accumulated in the lowest CP or formed aggregates along the white
matter (WM) (Fig.10I´´). In contrast to Lmo3 (accepted mostly as an IGL
neuronal marker), Lmo4 labels a small subset of L6a neurons and a portion of
L4-2 neurons (Bulchand et al., 2003). In the mutant cortex, more Lmo4+ L6a
neurons appeared at lower than their normal position, while Lmo4 expression
of the SGLs of the frontal cortex was almost completely abolished (Fig.10J/J´,
Fig.9D/D´).
We extended further our analysis by examining the expression of two
specific markers for L5 neurons, Clim1a, a cofactor for LIM-HD transcription
factors that labels only the deeper position of L5 neurons (Bulchand et al.,
2003) and Fezl, (Zfp312, Fez1), a putative TF containing a zinc-finger domain
(Inoue et al., 2004), and recently proposed to be involved in specification of
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the corticospinal motor neurons (CSMN, Ariotta et al., 2005; Molyneaux et al.,
2005). Fezl transcripts appeared to be enhanced in Pax6cKO cortex and
Fezl+ cell clumps were detected in CC above Hi (Fig.10K/K´´). Remarkably,
we found that the pool of Clim1a+ L5 neurons was clearly enlarged in the
Pax6cKO cortex at P10 (Fig.10I/I´´) as well as in the adult brain (Fig.14C/C´).
In addition, on almost adjacent sagittal sections at medial level, Clim1a, Lmo3
and Lmo4 label similar cell aggregates ectopically located in the WM and
RMS (Fig.10I´´/L´´). Thus, when Pax6 is not functional, subpopulations of
molecularly correctly specified IGL neurons (NSE+, Vglut+, Clim1a+, Lmo3+,
Lmo4+ and Fezl+) have migratory deficits, and the pool of subsets of IGL
neurons (Clim1a+, Fezl+, Lmo4+, Smi32+) appears to be enlarged. One
possibility that might explain the detected enhancement of subpopulations of
IGL neurons could be a failure in the specification of the late RG progenitors,
keeping on to produce neurons with early (IGL) identity even at late in
neurogenesis. To investigate this possibility, we performed BrdU labelling at
E16.5 (to label late-born neurons of SGLs) and studied the expression of early
IGL markers (Fezl and Clim1a) in the BrdU+ cells at stage E18.5 by double
ISH/IHC (Fig.10G/H).  Remarkably, no co-localization of these layer 5
markers with BrdU was found indicating that the increase of IGL neuronal
subtypes in Pax6cKO cortex is not due to a extended capacity of the late RG
to produce early neurons.
All together, our findings indicate that Pax6 plays an important role in
modulating the progenitor pool size and migratory ability of specific sub-
lineages of IGL neurons.
2.4. Er81 acts downstream of Pax6 in a subpopulation of L5
neurons in the rostral cortex
When applied as a L5 neuronal marker, the expression of the ETS
transcription factor Er81 (Brown and McKnight, 1992) was also altered in the
Pax6cKO  brain. One characteristic was a severe attenuation of Er81
expression in the parietal domain of the mutant cortex at P10 (Fig.11B/B´).
Analysis at E17.5 indicated that Er81 expression was markedly decreased in
the pallial VZ and CP (Fig.11D/E´). We identified potential binding sites for
Results
                                                                                                                            
38
Pax6 (Epstein et al., 1994) in location -1190 to –1225 in the mouse Er81
promoter (Coutte et al., 1999). Thus next we investigated direct binding of
Pax6 to this sequence by using Electromobility Shift Assay (EMSA). Results
of EMSA indicated that Pax6 protein binds to the Er81 promoter with a low
affinity as compared to a sequence of perfectly consensus binding site for
Pax6 (Fig.11G, lane 3 and 6). The specificity of the binding was controlled by
incubation with anti-Pax6 antibody, which super shifts the DNA-Pax6 protein-
Pax6 antibody complex (Fig.11G lane 7). Binding of Pax6 was completely
abolished after mutation of the binding site sequence (Fig.11G lanes 9, 10).
To determine whether the binding site in the Er81 promoter is indeed
occupied by Pax6 protein in vivo, the chromatin immunoprecipitation (ChIP)
assay was performed using mouse tissues of E15.5 WT cortex. In the
chromatin that was precipitated with Pax6 antibody, a fragment of 282 bp in
location –1322 to –1040 of the Er81 promoter covering the Pax6 binding sites
was detected, while region from –431 to –164 of the Er81 promorter (used as
an external control) was not amplified (Fig.11H). Together, this data indicate
that Pax6 protein binds both in vitro and in vivo to the Er81 promoter.
To study whether Pax6 can activate the Er81 transcription, we
transfected cell lines (Hela, NIH3T3) with a construct containing the Er81
promoter fused with a luciferase reporter (Er81-Luc) alone or together with the
Pax6 expressing plasmid CMV-Pax6 (Fig.11I). Control transfected cells
displayed a very low basal level of luciferase activity, whereas co-transfection
of Er81-Luc with an increasing amount of CMV-Pax6 led to robust luciferase
activity in a concentration-dependent fashion (Fig.11I). To examine whether
Pax6 is able to activate the Er81 promoter in a live embryo, we performed in
ovo coelectroporated chick embryos with Er81-Luc plus CMV-Pax6 and this
resulted in marked luciferase expression in contrast to the control co-
electroporations of Er81-Luc plus CMV-Gfp (empty vector) (Fig.11G/k´´).
These results indicate that pax6 could activate trans-activity of Er81 promoter
at both culture and in ovo experiment.
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Figure. 11. Pax6 directly regulates the activity of Er81 in pallial progenitors
 (A/B´) ISH analysis on cross sections at P10 reveals inhibition of Er81 expression in
L5 of the parietal (Par) cortex, but not in the medial frontal (Fr) cortex. (C/D´) showed
the expression of Er81 on sagittal sections of brains at E15.5 (C/C´) and E17.5
(D/D´). The arrows point to the expression of Er81 along the pallial-subpallial border,
while the arrowheads point to a strong ectopic expression of Er81 in the pallial
SVZ/IZ making connections with the olfactory bulb (OB) (C/D´).  Higher
magnifications of the images (D/D´) are presented in (E/F). In (D/D´) and (E/E´) note
the abrogation of Er81 expression in the progenitors of the pallial VZ and in the
cortical plate (CP), and the robust expression of Er81 in cell masses all along the
SVZ/IZ in the E17.5 mutant cortex. (F) is a more lateral sagittal section of E17.5
Pax6cKO brain than that shown in E´ demonstrating the enhanced Er81 expression
in two streams that extend across the LGE towards the OB, within the putative
territory of dLGE (arrow) and the ventral pallium (arrowhead). (G) EMSA of 32P
labelled probes for the potential Pax6 binding site in the mouse Er81 promoter and
Pax6 protein (see Supplementary Table 2). The arrowheads, the open arrow and the
close arrow show the free probes, the complex of probes with protein and the
complex of probes, protein with antibody, respectively. The difference between the
control probes (lane 1-4) and the others (lane 5-10) is due to the difference in lengths
of probes. Clear binding is detected for Pax6 to its potential binding site (lane 6). The
binding is not observed with the probe with the TNT rat reticulocyte (RRL) as a
protein control (lane 2). The specificity of the binding is controlled by incubation with
anti-Pax6 antibody, which makes DNA-Pax6 protein-Pax6 antibody complex to be
supershifted (lane 7). Binding of Pax6 was completely abolished after mutation of the
binding site sequence (lane 9, 10). (H) ChIP assay was performed to confirm the
direct interaction of Pax6 and Er81 promoter in vivo. Pax6 antibodies precipitate
chromatin, covering the region -1322 to –1040 of the Er81 promoter with the Pax6
binding site (lane 2), but not in the region –431 to –164 that is outside of the Pax6
binding site (lane 4). No binding is detected in absence of Pax6 antibody (lane 1). (I)
Pax6 activates the Er81 promoter-controlled reporter in co-transfected Hela cells.
The combinations and the amounts of plasmids used for co-transfections in the
performed six independent experiments are indicated. Error bars illustrate the
standard deviations (s.d.) of the relative luciferase activity in each assay. (J/K´´) The
activation of Er81 promoter-controlled reporter by Pax6 is also confirmed by ovo
electroporation in chick. Combinations of plasmids used for the experiment are
indicated. ChIP, Chromatin immunoprecipitation; CP, Cortical plate; EMSA,
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Electrophoretic mobility shift assay; Fr, Frontal cortex; Par, Parietal cortex; IZ,
Intermediate zone; SVZ, Subventricular zone; VZ, Ventricular zone;
Finally, to get additional proof that the identified regulatory sequences
in the Er81 regulatory element could correctly drive the endogenous
expression of Er81, we produced a transgenic mouse line (Er81Cre line). A
DNA construct was generated, containing a 2.0 kb NheI/Not fragment of the
Er81 promoter, which was placed upstream of a human ß-globin minimal
promoter was generated, followed by a Cre recombinase DNA sequence,
IRES and GFP reporter sequence (Fig.12A). The Er81Cre transgenic mice
were crossed with double-reporter mouse line, Z/AP reporter mice (Lobe et
al., 1999). Throughout all embryonic and adult stages, the Z/AP reporter mice
express the lacZ reporter gene before Cre-mediated excision occurs. Cre
excision, however, removes the lacZ gene, allowing expression of the second
reporter, the human alkaline phosphatase gene (hPLAP). This double-reporter
transgenic line is able to indicate the occurrence of Cre excision and to trace
the promoter-driven Cre activity in an extremely widespread manner from
early embryonic to adult lineages (Lobe et al., 1999). The analysis of hPLAP
activity in different founders of double transgenic line (Er81Cre, Z/AP)
revealed a similar expression pattern in L5, corresponded to that of the
endogenous Er81 in the cortex (arrowheads in Fig.12B/B´). Thus the 2.0 kb
fragment used in this study is indeed controls the expression of Er81 in
mouse cortex.
Together, these results indicate that Pax6 directly regulate the Er81
activity in pallial progenitors, possibly specifying a subpopulation of the L5
neurons of IGLs. This finding furthermore supports our proposal that the
transcription factor Pax6 may directly regulate the output of subsets of early
born IGL neurons. Noteworthy, the Er81+ expression was found also affected
in the rostral cortex of the Ngn1/Ngn2 mouse mutant cortex (Schuurmanns et
al., 2004). Because the endogenous level of Pax6 is highest in the progenitors
of VP and LP (Stoykova et al., 1997), Pax6 appears to control the generation
of Er81+ L5 neurons strictly in a region-specific manner, a phenomenon
dually reported in Pax6 regulation of Ngn2 (Scardigli et al., 2003).
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Figure 12. The generation of Er81Cre transgenic mice
(A) The Er81 promoter was subcloned in the upstream position of the ß-globin
minimal promoter (minPr) in a backbone plasmid, containing a DNA fragment
encoding Cre (Berger et al., 2004). This construct allows the Er81 promoter to
simultaneously drive expression of Cre and, via an IRES sequence, GFP reporter
sequence. (B/B´) After crossing with Z/AP reporter mice (Lope et al., 1999), hPLAP
staining of Er81Cre forebrains at E15.5 showed recombination in the L5 of the cortex
(B, view of cross section; B´, view of sagital section).
2.5. Pattern defect of the frontal cortex in Pax6cKO
In mouse corticogenesis, subventricular zone (SVZ) is a proliferative zone and
intermediate zone (IZ) is zone, where postmitotic neurons migrate towards the
cortical plate (CP). SVZ and IZ are formed at around E13 and E15,
respectively. In addition, tangentially migrating cells were generated in the
LGE cross the corticostriatal boundary and enter the SVZ/IZ of the neocortex
(DeDiego et al., 1994; Marin & Rubenstein, 2001; Wonders & Anderson,
2006; Kriegstein et al., 2006). Most intriguingly we observed that the inhibition
of Er81 expression in VZ of the rostrolateral Pax6cKO cortex at E17.5
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occurred together with a strikingly strong ectopic Er81 expression in the pallial
SVZ/IZ, making connection with SVZ of the olfactory bulb (OB, Fig.11D/D´)
and becoming visible already from E15.5 (Fig.11C/C´). Importantly, the
expression of Er81 in VP and dLGE of the mutant was enhanced (Fig.11F,
arrowhead and arrow, respectively), reflecting the widely documented
ventralization of the DV molecular patterning at PSPB in absence of Pax6 as
demonstrated for the Sey/Sey brain (Stoykova et al., 2000; Torresson et al.,
2000; Yun et al., 2001; Kroll and O´Leary, 2005). The expression of Er81 and
Dlx1/2 in VZ of the dorsal lateral ganglionic eminence (dLGE) specify
progenitors that join the rostral migratory stream (RMS) to reach OB where
they differentiate into GABAergic INs (Wichterle et al., 2001; Stenman et al.,
2003). As recently demonstrated by Long et al (2007), the expression of Er81
in SVZ at the level of the prefrontal cortex (PFC) is continuous between the
pallial and subpallial domain, thus possibly allowing cell migration of putative
cortical INs into the pallium (Wonders and Anderson, 2006). We studied the
distribution of GAD67+ INs in this particular forebrain region and found that
even at P10, more GAD67+ cells seem to delaminate from the enlarged SVZ
at the transition zone between OB and PFC (Fig.13M/M´´). Furthermore, the
enlarged GE at the PSPB in the mutant produced rostral ventricular
protrusions that abundantly express both Dlx1 and Er81 (Fig.13K/L). In
addition, while the expression of Er81 in L5 neurons of parietal cortex in the
mutant was substantially diminished, the MP and the dorsofrontal cortex
displayed a similar or even stronger Er81 signal (Fig.11A/A´). We presently
have no a direct evidence for the cell identity of the Er81+ cells in the
frontalmost Pax6cKO cortex. However based on our findings, we can propose
that an enlarged set of Er81+ INs might migrated from the rostralmost
subpallium during development, and/or Er81+ cells could be generated
postnatally by pallial progenitors with altered identity by the GE of the rostral
Pax6cKO cortex.
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Figure 13. Defects in the differentiation of the late RG progenitors in Pax6cKO
(A/E´) In collaborative study with Dr. M. Davidoff, University of Hamburg, we used a
combination of PAP- and ABC techniques to enhance the intensity of the
immunostaining with Nestin and GFAP antibodies. (A/C´) IHC with Nestin antibody
on cross sections from P10 brains showed Nestin+ RG cells with extending
processes towards pia (A/´A), but containing increased number of such cells along
RMS (C/C´). (B/B´) Nestin+ cells with astrocytic appearance are only scarcely seen
in SS cortex of the mutant. (D/E´) Labelling with GFAP antibody reveals absence of
differentiated astrocytes at uppermost position of the neocortex (D/D´, arrowheads),
and an enhanced presence of GFAP+ cells along the RMS (E/E´). (F/G´) Cross
sections were hybridized with Arx (F/F´) and Gad65 (G/G´) in situ probes. Note that
the mutant cortex contains enlarged sets of cells expressing the interneuronal
markers Arx and Gad67 in the germinative neuroepithlium (arrowheads) and in the
cortex. (H/I´) IHC for Calbindin28 antibody on sagittal sections shows enhanced
presence of Calbindin+ cells at uppermost position of the frontal Pax6cKO cortex.
(J/J´) The germinative epithelium (GE) and the Fr cortex contain enlarged set of
PLP/DM20+ oligodendrocytes in the Pax6cKO. (K/L) The ventricular protrusions of
GE of the Fr Pax6cKO cortex abundantly express Dlx1+ (K) and Er81+ (L). (M/M´´)
Cross sections at the level of the prefrontal cortex (PFC) brains hybridized with
Gad67 in situ probe. Note the enlarged SVZ of the OB in the mutant from which
Gad67+ cells appear to delaminate and populate the frontalmost cortex. BG, basal
ganglia; DG, Dentate girus; Fr, Frontal cortex; Hi, Hippocampus; RMS, LMS, rostral
or lateral migratory stream; Hi, hippocampus; OB, olfactory bulb; PFC, prefrontal
cortex; Str, Striatum; SVZ, Subventricular zone.
2.6. Defect of the differentiation of the pallial late RG
progenitors in Pax6cKO mice
Next we took the advantage of the Pax6cKO mice to examine whether the
previously reported lack of SGL neurons in the prenatal Sey/Sey cortex is due
to a delay of the RG differentiation. Late RG cells (E16-E19) generate
neurons for SGLs, and astrocytes, while a small population of RG maintains
progenitor properties at early postnatal stages. When tested at P10 for the
expression of the progenitor cell marker Nestin, it was possible to visualize
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Nestin+ RG cells extending their processes towards the pial surface in the
control cortex, while the Pax6cKO  cortex was depleted of such cells
(Fig.13A/A´). Nestin+ cells with an astrocytic morphology were abundant in
parenchyma of the somatosensory and occipital cortex in the control, but not
in the mutant mice (Fig.13B/B´; and data not shown). However, an excess of
Nestin+ astrocyte-like cells was seen along the lateral migratory stream (LMS)
and rostral migratory stream (RMS) (Fig.13C/C´) in the Pax6cKO brain.
Immunostaining with anti-GFAP antibody in the Pax6cKO brain showed
defective distribution of GFAP+ cells with astrocyte-like appearance as these
cells were severely diminished or virtually absent at the position of SGLs
(Fig.13D/D´), which however appeared more abundant along the SVZ/LMS
and RMS (Fig.13E/E´). Furthermore, a substantial portion of the cells in the
enlarged RMS of the mutant brain clearly showed a strong expression of Arx
and GAD67 , two markers that specifically label migratory subpallial
GABAergic INs (Fig.13F/G´). Consequently, the frontal cortex of Pax6cKO
contains enlarged sets of GABAergic INs of both Arx+ and GAD67+ types as
well as enlarged set of Calbindin 28+ cells, probably representing migrating
INs from the subpallium (Fig.13H/I´).
In the rodent forebrain the majority of oligodendroglial progenitors arise
during late embryogenesis and early postnatal development from multipotent
cells of the SVZ of the lateral ventricles. SVZ cells migrate away from these
germinal zones to populate both developing white and gray matter, where
they differentiate and mature into myelin-forming oligodendroglia (Levison and
Goldman, 1993). Given the enhanced expression of progenitor markers in the
enlarged GE the postnatal Pax6cKO brain, we probed the expression of the
two oliogodendroglial markers, Olig2 and PLP/DM20. We found a profoundly
enhanced expression of both these markers in the Pax6cKO as compared to
the control cortex (Fig.13J/J´, data not shown).
In summary, these results demonstrate severe defect in the
differentiation of late RG cells in Pax6cKO: the differentiation of late RG is
blocked, leading the abrogation of generation of neurons of SGL projection
neurons, in expense of an enhanced pool of cells with progenitor/stem-like
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properties in neurogenic zones of the postnatal brain that produce more INs
and oligodendrocytes, possibly even postnatally.
2.7. Cytoarchitecture of the Pax6cKO cortex at maturity
Figure 14. Cortical abnormalities in the adult Pax6cKO mice
(A/B´) Cresylviolet staining of cross sections of adult (7 months old) brains confirmed
the dysgenesis of SGL neurons and revealed an increased number of cells with the
pyramidal morphology at the uppermost position in the Pax6cKO cortex. Trapped
cells are kept along the corpus callosum (CC) in the mutant brain (A´, pointed by
arrowheads). (C/D´) ISH with Clim1a probe (C/C´) and IHC with Smi-32 antibody
(D/D´) support the observation that more cells with the pyramidal morphology are
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present in the Pax6cKO cortices. (E/E´) Haematoxilin & eosin (H&E) staining showed
a large population of dark-stained cells are accumulated within the germinative
neuroepithelium of the rostral cortex of Pax6 mutant (pointed with arrow). (F/F´)
Pax6cKO brain at maturity also showed an absence of the anterior commissure (the
commissure is pointed with arrow). (G/G´) Higher magnification of the CA1 region
showed the densely accumulated cells in the periventricular zone (pPv) above Hi
(arrowheads). The big cells in str. oriens (small arrows) seem to delaminate from pPv
towards CA1 in the mutant. (I/I´) The subgranular layer of dentate girus (DG) in the
mutant contains a larger set of cells (arrowheads) with appearance of progenitors
possibly supplying more newborn neurons in the adult mutant DG and Hi suggested
also by the results after immunolabelling with SMI-32 antibody (see Fig. 16G/H´). CC,
Corpus callosum; OB, Olfactory buld; Str.or, Stratum oriens;
The observed defects in the cortical layer formation and neuronal
differentiation in Pax6cKO brains are preserved at adulthood. Morphological
analysis of haematoxilin & eosin (H&E) and cresylviolet staining of sections
from adult (3-7 months old) brains of the Pax6cKO mice revealed a reduced
thickness of SGL in the entire cortex (Fig.14A/B´). The thinning of the
neocortex in Pax6cKO was more profound in the frontoparietal areas, where
the cortex appears to contain at a most upper position cells with the pyramidal
morphology. Indeed, immunostainig with SMI-32 antibody and ISH with
Clim1a probe (general markers for L5 pyramidal projection neurons) revealed
a superficial location of a large pool of SMI-32+, Clim1a+ pyramidal neurons
in the Pax6cKO cortex (Fig.14C/D´). Small dark cells, abundantly populate the
germinative neuroepithelium of the rostral cortex (Fig.14E/E´). In consistence
with the discovered dysgenesis of the SGLs, the corpus callosum (a thick
axonal tract that connects the left and right cerebral hemispheres) was
severely underdeveloped in the Pax6cKO mutant (Fig.14F/F´). The mutant Hi
appeared enlarged with higher cell density in the str. pyramidale, while the
pPv above the Hi contained a dense population of progenitor-like cells from
where large cells with a pyramidal appearance seem to migrate towards the
CA1 (14H/I´).
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2.8. Defects of the neuronal differentiation of Pax6cKO
hippocampus
In the adult hippocampus, neurons are generated from progenitor cells
located in the subgranular zone (SGZ) of the dentate gyrus (Kempermann et
al., 2004, Ming and Song, 2005 and Lledo et al., 2006). The expression of
Pax6 in cell lineages in hippocampus has been studied previously. Similar to
VZ of the cerebral cortex, Pax6 shows a co-expression with GFAP and
Nestin, markers of astrocyte-like and progenitor cells in SGZ of the
hippocampus (Maekawa et al., 2005 and Nacher et al., 2005).
The expression patterns of Vglut1 at P10 (Fig.15A/A´) and the morphological
analysis of the adult (Fig.15G/G´) revealed the presence of a thicker str.
pyramidale in the Hi of Pax6cKO, suggesting augmentation of this cell
population. The subbiculum, CA1-CA3 domains, and DG in Pax6cKO brain at
P10 showed a stronger immunoreactivity with the Smi-32 antibody, although
at this stage only a few of the labeled neurons were differentiated, extending
processes (Fig.15C/D´). Interestingly, the Hi of 7-months old mutants,
displayed a striking increase of the cell number of Nestin+ cells in str. oriens,
PSA-NCAM+ newly born neurons in CA1-CA3 and str. radiatum, and Smi-32+
highly differentiated pyramidal neurons in all these three regions (Fig.15E/H´).
Further experiments are needed to study the exact origin of the enlarged set
of PSA-NCAM+ young and Smi-32+ differentiated pyramidal neurons  in Hi of
Pax6cKO. It is also interesting to note that after a BrdU-pulse labeling at
E16.5 and E18.5, more BrdU+ cells were detected in Pax6cKO as compared
with the control in both the enlarged GE at PSPB as well the HiSVZ and in the
depth of DG and CA1 (Fig.9K/L´). Parentally they generate granule neurons of
DG and astrocytes. At older stages derivatives of HiSVZ migrate into the
pyramidal and molecular layers of CA1-CA3 where they adopt non-pyramidal
morphology (Navarro-Quiroga et al., 2006). Thus, our present findings
suggest that the enhanced presence of PSA-NCAM+ and Smi-32+ pyramidal
neurons in the Hi of Pax6cKO possibly involves a postnatal neurogenesis
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from progenitors kept in the adult HiSVZ and/or pPv zone (see discussion;
also Nakatomi et al., 2002).
Figure 15. Impairment of hippocampus in Pax6cKO brain at P10 and in 7
months old brain
Sagittal sections from P10 brains processed for ISH (A/B´) or IHC (C/H´) with
markers as indicated. (A/A´) Stratum pyramidale of hippocampus in Pax6cKO is
augmented and densely packed with Vglut1+ neurons, which are also seen all along
the WM above hippocampus (arrowheads in A´). (B/B´) The enlarged HiSVZ in
Pax6cKO (arrowhead) contains more Gad67+ INs that seems to populate the hilus of
the dentate girus (DG). (C/D´) The entire Ammon horn of hippocampus, DG and
Subiculum show a strong Smi-32 immunoreactivity in Pax6cKO. The arrowheads in
(D´) point to Smi-32+ cell masses along the WM above hippocampus. (E/H´)
Immunolabelling of sagittal sections from adult brain (7 months old) with antibodies
as indicated. Note that the enlarged str. or contains many more Nestin+ cells in
Pax6cKO brain (E/E´). Stratum oriens, Stratum pyramidale of CA1, and Stratum
radiatum in the mutant contain enlarged set of differentiating PSA-NCAM+ neurons
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(F/F´). The entire ammon horn of the Pax6cKO hippocampus is densely populated by
Smi-32+ pyramidal cells, which branch extensively into Stratum oriens and Stratum
radiatum (G/G´). In the mutant, the subgranular germinative zone (arrow) contains
more Smi-32+ neuronal cell bodies, extending processes (H/H´). DG, Dentate girus;
Hi, hippocampus; Sub, Subiculum; str. or, Stratum oriens; str. pir, Stratum
pyramidale; str. rad, Stratum radiatum;
2.9. The Pax6cKO cortex shows molecular caudalization
but normal thalamocortical targetings
Analyses of the cortical phenotype of Sey/Sey embryos suggest that the
robust rostro-lateralhigh to caudo-mediallow gradient of Pax6 in RG progenitors
plays an essential role in the functional arealization of the developing cortex
(Bishop et al., 2000, 2002; Muzio et al., 2002). In contrast to the Small eye
mutant, the sensory thalamus in the Pax6cKO mice is not affected, giving us
the unique opportunity to directly examine whether Pax6 function in the cortex
is autonomously required in establishment of area identity.
We first studied the molecular regionalization of the Pax6cKO cortex at
P10. Most of the known genes that outline borders between distinct cortical
areas show regionalized expression in the SGLs and therefore have limited
value in studying the molecular regionalization of the cortex in the Pax6cKO
mice. Notably, in addition to their expression in SGLs, both Cadherin8 and Id2
are strongly expressed in L5 of the caudal cortex with a rostral limit within the
SS cortex. As expected, the expression of both markers extends ectopically
beyond the assumed M/SS border in the mutant (Fig. 16A/B´). The SS area,
as revealed by histochemsitry for cytochrome oxydase in a flatmount
preparation, seemed to have similar size in both genotypes, but in the mutant
cortex the SS domain appeared to be located at a slightly more rostral
position as compared to the control (data not shown). Notably, the rostral
EphA7 +domain, normally confined to the Fr cortex (Garel et al., 2003),
looked diminished in the Pax6cKO brain (Fig.16C/C´), and the expression of
both EphA7  and RZRß  in the occipital cortex was shifted rostrally
(Fig.16C/D´). Thus, in accordance with previous data for Small eye, Pax6cKO
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mice also exhibit a reduction of the Fr cortex and a complimentary expansion
of the regionalized expression of caudal cortical markers.
Figure 16. Pax6LOF causes molecular caudalization of the cortex without
change of the cortical area identity
(A/D´) ISH analysis on sagittal sections from P10 brains was used with regional
markers, as indicated. (A/B) In the controls, the strong expression of Cad-8 and Id2
in SGL of the motor (M) cortex (arrows) and in L5 (arrowheads) marks a border
between the M and SS areas. (A´/B´, arrowheads) in Pax6cKO, the expression of
both markers in SGLs is not detectable, however the rostral limit of their expression
in L5 extends ectopically from somatosensory (SS) into the M cortex. (C/C´) The
regionalized expression of EphA7 confined to the M cortex outlines a smaller territory
in the Pax6cKO. The relative size of the caudal EphA7+ and RzRß+ domains
appeared enlarged in the Pax6cKO. The arrows and the arrowheads indicate the
limits of the gene expression in the caudal or rostral cortex, respectively (C/D´).
(E/F´) Topographic organization of TCA projections in Pax6cKO mutant is preserved.
(E/E´) After placement of DiI (red) and DiA (green) crystal in the visual (Vi) or SS
cortex, the dye diffusion correctly labels the dLGN or VB in both control and KO
brains. (F/F´) After DiI crystal placement in the VP nuclei of the thalamus, the barrel
field pattern is partially preserved in Pax6cKO. dLGN, Dorsal lateral geniculate
nucleus; M, motor cortex; SS, somatosensory cortex; TCA, thalamocortical axon; Vi,
visual cortex; VP, Ventroposterior;
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To directly assess the area identity in the Pax6cKO mice we traced the
thalamocortical axon (TCA) projections using retrograde labeling (in
collaboration with Dr. Zoltan Molnar, Oxford University). Surprisingly, despite
the change in the expression of area specific markers, when carbocyanine
dye crystals (DiI and DiA) were placed in the putative motor (M1),
somatosensory (S1), or visual (V1) cortical areas, TCA projections correctly
targeted the ventroanterior (VA), ventroposterior (VP) nuclei, and the dorsal
lateral geniculate nucleus (dLGN) of thalamus respectively (Fig.16E/E´). The
same pathways were evident when the carbocyanine crystals were placed in
different thalamic nuclei (VA, VP, dLGN) and retrograde labeled cells were
found in the correspondent cortices (M1, S1 or V1, respectively). After
placement of DiI crystals in the VP nucleus of thalamus, clusters of labeled
terminals were found in the residual L4 of the barrel field of S1 in the mutant,
although not entirely separated as in the control animals (Fig.16F/F´).
These findings indicate that despite the observed caudalization of the
molecular properties of the cortex, the cortical areal identity as well as the
cortical module arrangement is unaltered in Pax6cKO mice.
2.10. Trim11 interacts with Pax6
Previous evidence indicated a dependence of the eye and cortical phenotype
on Pax6 dosage (Hill et al., 1991; Schedl et al., 1996; Berger et al., 2007;
Manuel et al., 2007, see discussion). Given the important functions of Pax6
during corticogenesis as described in this work, we were further interested to
study some molecular mechanisms that control the Pax6 expression in the
cortical cells. To identify proteins that interact with Pax6 and possibly
modulate its activity, we carried out a two-hybrid screening using Pax6PD
(Pax6 without PD) as a bait and a cDNA library derived from E15.5 cortex of
mouse (Fig.17A). Yeast colonies were selected on plates lacking the leucine,
tryptophan and histidine, and supplemented with 65 mM 3-aminotriazole. All
these clones were assayed for -galactosidase activity and confirmed by
sequencing. In total of 116 independently positive colonies from 2.5x106
library transformants, four sequences were found to encode for Trim11, the
reported ubiquitin E3 ligase of neuroprotective peptide humanin (Niikura et al.,
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2003). Sequences of two colonies cover the full-length of Trim11 cDNA with a
point mutation at C-terminal. The shortest sequence corresponds to the full
coiled-coil domain, flanked by the partial B-box and B30.2 domain (Fig.17B).
The characterization of the other sequences encoding different potential
interacting proteins of Pax6 is in progress.
To validate our two-hybrid screen result we performed a pull-down
assay using full-length of the purified GST-fused Trim11 and a cell lysate
containing the full-length Pax6 protein. As shown in Fig.17C, Pax6 binds
physically to Trim11
Figure 17. Pax6 interacts physically with Trim11
(A) The schematic representation of the functional domains of Pax6 which contains
the two DNA-binding domains the pair domain (PD) and the homeobox domain (HD),
the glycine-rich region (Gln) and the activation C-terminal domain. Construct of Pax6
without the pair domain (Pax6PD) was used in the yeast two-hybrid screening. (B)
Five different controls (a-e) are shown according to the supplier ´s manual. Four
independently positive colonies revealed potential interactions of Pax6 and Trim11 in
the yeast two-hybrid assay. (C/D) The interaction of Trim11 and Pax6 were assessed
by the pull-down assay (C) and immunoprecipitation assay (D). The upper, middle
and lowest blots show the elutants from the pull-down or immunoprecipitation assay
and the amount of proteins (input) used in the experiments, respectively. Note that
the experiments were performed in the presence of 20 μM MG132 proteasome
inhibitor (C/D).
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(lane 2), and does not bind to GST alone, which was used as a negative
control (lane 1). To confirm the interaction of Trim11 with Pax6 in mammalian
cells, a plasmid for N-terminal HA-tagged Trim11 (HA-Trim11) or the
backbone plasmid (negative control) were transiently transfected with an
expression plasmid for mouse Pax6 cDNA (CMV-Pax6) in Hela cells. In
accordance with the finding in the pull-down assay, HA-Trim11 was
specifically coimmunoprecipitated with Pax6, which only marginal band was
seen with the negative control (Fig.17D). In consistence with previous data,
the performed analysis of the Trim11 subcellular localization indicated that
HA-tagged Trim11 distribute diffusely between the nucleus and cytoplasm in
Hela cells (Fig.18E/F´; Reymond et al., 2001; Niikura et al., 2003). Trim11
transcripts are ubiquitously distributed in developing mouse tissue at E12.5,
but most abundantly they are presented in the CNS (central nervous system).
In the telencephalon at E12.5, the expression of Trim11 is mostly confined to
cells in VZ of the neuroepithelium (Reymond et al., 2001), where Pax6 is
strongly expressed as well, suggesting that these proteins might interact in
vivo. In this line of evidence, immunostaining for Pax6 and Trim11 of Hela
cells, cotransfected with CMV-Pax6 and HA-Trim11, showed a colocalization
of both proteins in the nucleus (Fig.18E/F´, pointed by arrowheads in F´).
2.11. Trim11 induces ubiquitination and affects the steady-
state levels of Pax6 protein
Finding the interaction between Pax6 and Trim11, an E3 ubiquitin ligase of
Humanin peptide (Niikura et al., 2003), prompted us to investigate whether
Trim11 also has a role in controlling the degradation of Pax6 through the
ubiquitin-proteasome system (UPS).
We first analyzed the half-life of Pax6 in the presence or absence of
Trim11 by using cycloheximide-chase experiments. This approach is widely
used for study the protein stability (Obrig et al., 1971). Shortly, after a
cycloheximide-dependent inhibition of translation of the protein biosynthesis
by binding with the 80S ribosome of the cells, the half-life of the questioned
protein is determined. As shown in Fig.18A, a dramatic decrease of Pax6 half-
life in the presence of Trim11 was observed. After 90 min of the chase
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experiment, more than 90% of the Pax6 protein was degraded. Under similar
experimental conditions, but in the absence of Trim 11, the half-life of the
Pax6 was only slightly affected (Fig.18A, lower diagram represents for amount
of proteins in different time points in lower blots).
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Figure 18. Trim11 induces ubiquitylation and affects the steady-state levels of
Pax6 protein
(A) Cycloheximide–chase assay was used to assess the effect of Trim11 on the
steady-state level of Pax6. Upper and lower blots show the levels of Pax6 in Hela
cells after transfection with CMV-Pax6 construct together with either HA-Trim11 or
with the empty vector, respectively. The quantification of Pax6 protein levels at
different time points in cycloheximide–chase assay is also presented as a diagram.
(B) Trim11-mediated ubiquitination of Pax6 was proved using an in vivo ubiquitination
assay. Hela cells were transfected with plasmids as indicated. The immunoblotting
analysis of elutants from the anti-Flag immunoprecipitation using anti-His antibody
showed a much stronger smear band for the ubiquitinated Pax6 (lane 1, upper blot)
in the presence of Trim11 as compared to controls (in the absence of Trim11 or
Pax6, lane 2, 3 of upper blot). Note that in the lower blot using an anti-Pax6 antibody
there is a substantial reduction of the Pax6 protein level. (C) The proteasome
inhibition assay confirmed the UPS-mediated degradation of Pax6. Hela cells were
transfected with plasmids and treated with the proteasome inhibitor (MG132) as
indicated. In presence of the MG132, the level of Pax6 was recovered significantly
(compare levels of Pax6 protein in lanes 2 and 3 of the upper blot). (B/C) Blots with
anti-HA antibody showed an equal amount of the Trim11 protein was used in each
experiment. The lowest blots using an anti-Actin antibody shows an equal amount of
total protein was loaded for SDS-PAGE. (D/F´) The colocalization of Pax6 and
Trim11 and the Trim11-mediated degradation of Pax6 were confirmed by double ICC
analyses using HA and Pax6 antibodies. Hela cells were transfected with CMV-Pax6
plasmid alone (D/D´) or together with HA-Trim11 (E/E´). In the presence of Trim11,
the number of Pax6-imunoreactive cells was severely diminished and the expression
level of Pax6 in some Pax6-remaining cells was decreased as illustrated by a much
less dense staining (E/E´) when compared to the control (D/D´, without Trim11).
Overlay images of Trim11 and Pax6-immnoreactive cells showed the colocalization
of Trim11 and Pax6 in transfected Hela cells (E/F´ and F´ which is a higher
magnification image of the rectanglor block in E, E´, F).
To confirm that the decrease in the half-life of Pax6 is dependent upon
the activation of Trim11 expression, we performed cotransfection of Hela cells
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with plasmids of CMV-Pax6 and HA-Trim11. Western blot analysis revealed
the level of Pax6 was severely diminished in the presence of Trim11 when
compared to control (Fig.18B, lane 1-2; Fig.18C, lane 1-2). Next we tested
whether the activation of Trim11 could also mediate the degradation of
endogenous Pax6 protein. For that, we utilized a primary cortical cell culture
system. In our system we used primary cells originating from tissues of E12.5
mouse cortex. After electroporating cells with CMV-Trim11, they were cultured
for 3 days in vitro (3DIV), in a chemically defined culture medium (see
Material and Method; Bottenstein & Sato, 1979). Under these culture
conditions, progenitor proliferation and neuronal differentiation in vitro mimic
those in vivo (Qian et al., 2000). Consistently, the overexpression of Trim11
(through CMV-Trim11) led to a substantial reduction of endogenous Pax6 as
indicated by the decreased number of Pax6-positive cells in primary culture
(Fig.19A/C´, see in detail below).
In vertebrates, two Pax6 isoforms are active, Pax6 and Pax6(5a)
(Fig.7; Carriere et al., 1995; Richardson et al., 1995; Zaniolo et al., 2004). To
determine whether the decrease of Pax6-positive cells might involve down-
regulation of Pax6 transcription, we performed quantitative PCRs to determine
the mRNA levels of Pax6 and Pax6(5a). Samples were isolated from 3DIV
cortical primary cultures after electroporation with the plasmid CMV-Trim11
plasmid or the backbone plasmid (negative control). In contrast to the
decrease in the level of Pax6 protein revealed by ICC detection, we did not
observe any significant change in the mRNA level of either Pax6 or Pax6(5a)
(data not shown). Thus the enhanced expression of Trim11 accelerates the
degradation of Pax6 protein, but does not affect the transcription of both Pax6
isoforms.
We next assessed whether Pax6 can serve as a substrate for the
ubiquitin ligase activity of Trim11. For this purpose, we overexpressed Trim11
together with Pax6, and His-tagged Ubiquitin (His-Ub) in the presence of the
proteasome inhibitor MG132 and analyzed the appearance of Ub-conjugated
forms of Pax6 (Fig.18B). After immunoprecipitation of Flag-Pax6, blotting
using anti-His antibody revealed a large amount of Pax6 was ubiquitinated in
the presence of Trim 11, (Fig.19B, lane 1). This band was very faint in the
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absence of Trim11 (Fig.18B, lane 2) or Pax6 (Fig.18B, lane 3), indicating that
Trim11 mediates the ubiquitination of intracellular Pax6.
Proteasomes are large protein complexes, located in the nucleus and
the cytoplasm of all eukaryotes. The main function of the proteasome is to
degrade unneeded or damaged proteins by proteolysis, a chemical reaction
that breaks peptide bonds. Tagged proteins for degradation are normally
labeled by ubiquitin in the reaction chains of ubiquitination (Hochstrasser,
2006). As Pax6 is extensively ubiquitinated by Trim11, we next examined
whether the degradation of Pax6 is truly mediated by Trim11 through the
ubiquitin proteasome system (UPS). We compared the expression level of
Pax6 in Hela cells after cotransfection of Pax6 and Trim11 in the presence or
absence of the proteasome inhibitor, MG132. Consistently Trim11 could
ablate almost completely of Pax6 protein in comparison with the negative
control (Fig.18C, lane 1, 2), however in the presence of the proteasome
inhibitor, the level of Pax6 was recovered significantly (Fig.18, lane 3).
Collectively our data indicate that that Trim11 indeed mediate the degradation
of Pax6 via UPS.
2.12. The degradation of Pax6 by overexpression of Trim11
results in repression of neurogenesis
As decribed above, we examined the effect of overexpression of Trim11 in
E12.5 cortical primary cultures. Three days after culturing in vitro (3 DIV) in a
chemically defined culture medium (see material and method; Bottenstein &
Sato, 1979), the overexpression of Trim11 (via the expression vector CMV-
Trim11) led to a decrease in the number of cells immunoreactive for
endogenous Pax6 (CMV-Trim11 transfected cells contained 9.8%±0.4%
Pax6-immunoreactive cells; 191 Pax6-immunoreactive cells/1939 total cells/in
5 times of 20x objective) as compared to controls (22.4%±0.5% Pax6 positive
cells; 481 Pax6-immunoreactive cells/2147 total cells/in 5 times of 20x
objective; P<0.005; Fig.19A/C).
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Figure 19. Suppression of cortical neurogenesis after overexpression of
Trim11
Primary cells derived from E12.5 WT cortical tissues (A/K´) or Sey/Sey (M/Q´) were
electroporated with either an empty vector (controls, in   A/P´) or with a construct to
overexpress Trim11 (CMV-Trim11 in B/Q´). After 3 DIV, ICC analyses were
performed with Pax6 antibody (A´/B´) and different antibodies to identify either
progenitors (Nestin+ cells, in D/E´, M/N´), neurons (Tuj+ cells in G/H´, P/Q´) or
astrocytes (GFAP+ cells in J/K´). DAPI staining is represented on the left side of
each of the immunostained slides. Graphs on the right side show results from the
quantitative analysis of expression for these markers. Error bars give standard
deviations (s.d.).
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Immunostaining with a marker for progenitor cells (Nestin+) indicated a
slight enhancement of the number of Nestin+ cells in the CMV-Trim11
transfected cells (57.6%±2.1%; 738 Nestin-immunoreactive cells/1282 total
cells/in 5 times of 20x objective) as compared to the control cultures
(52.7%±1.7% ; 782 Nestin-immunoreactive cells/1485 total cells/in 5 times of
20x objective) in the control P<0.005 ; Fig.19D/F). On the contrary, the
labeling with Tuj1, a marker for postmitotic neurons, indicated that CMV-
Tr im11  transfected cells contain less neurons (30.9%±2% Tuj1-
immunoreactive cells; 396 Tuj1-immunoreactive cells/1282 total cells/in 5
times of 20x objective) as compared to the controls (41.7%±0.9%; 619 Tuj1-
immunoreactive cells/1485 total cells/in 5 times of 20x objective; P<0.005,
Fig.19G/I). Notably, while the Nestin+ cells had mostly bipolar morphology,
Tuj1+ cells had branched processes in CMV-Trim11 transfected cells
(Fig.19E´/G´, with arrowheads). In addition, we found that the overexpression
of Trim11 did not affect the number of GFAP-positive cells, when
electroporated cells were cultured for 3-5DIV in Sato medium or for 5-7DIV in
a condition for astrocyte differentiation (see Mateial and Method; Fig.19J/L).
We asked further whether the observed inhibition of neurogenesis after
the overexpression of Trim11 was specifically due to degradation of Pax6
alone. We performed a similar experiment for overexpression of Trim11 in
cortical primary cultures that originated, however, from Sey/Sey cortex, which
is completely devoid of Pax6 (Hill et al., 1991). Remarkably, no significant
change in the number of Tuj- and Nestin-positive cells was detected in these
experiments (Fig.19M/R). These results are in full agreement with the
detected enhancement of progenitor proliferation and abrogation of neuronal
differentiation when Pax6 is not functional in vivo, as shown in the Sey/Sey
cortex (Gotz et al., 1998; Heins et al., 2002). Together, these findings indicate
that in addition to the intrinsic role of Pax6 in endowing the radial glial cells
with neurogenic features (Heins et al., 2002), possibly the Pax6-interacting
partner Trim11 modulates indirectly the neuronal cell fate decision by
facilitating the degradation of Pax6.
Results
                                                                                                                            
62
2.13. Trim11 is a potential direct downstream gene of Pax6
We recently generated a mouse line to allow us to study the effect of
overexpression of Pax6 in transgenic mice in vivo (Berger et al., 2007). A
construct was generated, in which a DNA sequence encoding for GFP, was
flanked by two loxP sites and placed in front of the Pax6 cDNA. In the
absence of Cre activity, CMV promoter drives the expression of GFP in all
body regions of these transgenic mice. However the presence of Cre activity
leads to excision of the sequence between the two LoxP sites, allowing the
activation of Pax6. In order to conditionally activate the expression of Pax6 in
cortical progenitors and postmitotic neurons, respectively (Berger et al.,
2007), we used different cell lineage-specific Cre lines, Emx1Cre (Gorsky et
al., 2002) and NexCre (Goebbels et al., 2006)
To study whether Trim11 might not only act upstream, but also
downstream of Pax6, we examined Trim11 RNA levels in embryonic cortex
isolated from transgenic mice after overexpression of Pax6 in cortical
progenitors at the onset of neurogenesis at E9.5 (Emx1Cre,JoP6) or in
cortical postmitotic neurons (NexCre,JoP6) and corresponding controls
(Berger et al., 2007). Surprisingly, qPCR analysis showed a substantial
increase in Trim11 transcripts in both experimental conditions, when
compared to controls (Fig.21A). We observed 1.9 and 1.7 fold higher levels of
Trim11 RNA in samples isolated from Emx1Cre;JoP6  at E12.5 and
NexCre;JoP6 at E15.5, respectively (Fig.21A). Interestingly, examination of a
genomic sequence, including the 5 kb upstream of the starting codon of
Trim11 revealed the presence of multiple putative Pax6 binding sites. Band
shift and super-shift assays (similarly to those performed in the study of the
Er81 promoter) showed that Pax6 does indeed bind strongly to three
synthesized double-stranded oligos corresponding to putative Pax6-binding
sites out of the eight tested ones (lane 4-5, 12-13, 18-19; probe a, e, h;
Fig.20B/B´). Even though further experiments are required to confirm a direct
interaction, our preliminary data suggest that Pax6 might directly regulate the
expression and activity of Trim11. Thus, our findings also suggest the
existence of an autoregulatory loop between Pax6 and Trim11.
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Figure 20. Potential autoregulatory feedback loop regulates the activity of Pax6
and Trim11.
(A). qPCR analysis performed with cortical samples isolated from transgenic mice
after overexpression of Pax6 (as described in Berger et al., 2007) in cortical
progenitors (JoP6;Emx1Cre) or in postmitotic neurons (JoPax6;NexCre) showed
elevated expression levels of Trim11 when compared to the corresponding control.
(B) EMSA assay (similar to that described for the Er81 promoter) demonstrated that
Pax6 binds strongly to three out of the eight putative binding sites for Pax6. (B´)
Pax6-binding sites are located in the 5´ upstream region of the starting codon and a
genomic region inbetween exons 3-4 of Trim11. (D) Schema presents an assumed
model of the genetic interaction between Pax6 and Trim11, possibly forming an
autroregulatory feedback loop. On the one hand Trim11 protein binds to Pax6 and
acts as a Pax6-specific E3 ubiquitin ligase, which attaches ubiquitin residues onto
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Pax6 and send it for degradation by the 26S proteasome. On the other hand, Trim11
gene is a downstream target for positive transcriptional activation by Pax6. This
interplay between Pax6 and Trim11 defines a basal Pax6–Trim11 loop. As long as
the loop is fully close, the balance seems to be in favor of the Pax6 level and
maintenance in a biological state. Any shift in this balance, such as in over-dosage of
Pax6 would result in abnormal cellular responses such as apoptosis and changing of
adhesive properties (Berge et al., 2007; Manuel et al., 2007). To limit such harmful
conditions, an auto-regulatory feedback program in cells could response by activating
Trim11 in order to repress the over-dosage of Pax6.
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3. Discussion
The aims of this project were to get conclusive results on the proposed (but
not confirmed) regulatory role of Pax6 in the specification of neurons of
distinct cortical layers, area formation, and to attempt to identify molecular
mechanisms regulating the expression level of the neurogenic factor Pax6 in
cortical progenitors.  Firstly, we have demonstrated that Pax6 has a crucial
role for the correct differentiation of the late RG and thus for the specification
of SGL neurons. Secondly, in contrast to previous suggestions we found that
Pax6 is not involved in the generation of IGL neurons, rather we showed that
Pax6 affects the migration, and the pool size of subsets of IGL neurons. In
further support of this idea, we provided evidence that Pax6 directly regulates
the activity of the transcription factor Er81, a putative instructive factor for
layer 5 neurons, in the pallial progenitors. Thirdly, we found while it is
expressed in a prominent rostral-high to caudal-low expression gradient in the
cortical progenitors, Pax6 affects the molecular regionalization of the cortex,
but does not influence the establishment of cortical area identity. Finally, we
demonstrated that the E3 ubiquitin ligase Trim11 controls the stability and
may be modulate the expression level of Pax6 protein in cortical progenitors.
We further presented evidence for a possible interplay between Pax6 and
Trim11, possibly forming an autoregulatory feedback loop that controls Pax6
function during neurogenesis and developing cortex.
3.1 Pax6 in the neuronal differentiation and formation of
cortical layers
Mammalian corticogenesis is a process in which progenitor cells generate
neurons destined for specific cortical layers, depending on the expression of
layer-determinant genes and environmental cues. The mechanisms
underlying the formation of cortical layers have been recently explored by
analyzing a single or combination of mutants of neuronal determinant factors.
The current view suggests that distinct genetic programs operate at different
stages of corticogenesis to specify neurons of different cortical layers (Fig.6;
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reviewed by Campbell, 2005; Guillemot et al., 2006). Recent data suggested
that generation and specification of the early-born IGL neurons is largely
dependent on the function of Foxg1, Tbr1 and the proneural genes Ngn1/2,
while the late-born cortical neurons of SGLs are specified in an Ngn-
independent pathway, requiring the synergistic activities of Pax6 and the
orphan nuclear receptor Tlx (Schuurmans et al., 2004; Schmahl et al., 1993;
Caric et al., 1997; Land and Monaghan, 2003). However our present findings
indicate that Pax6 plays a crucial role in the neuronal generation of both IGLs
and SGLs (see the proposed model in Fig.21).
Figure 21. A proposed model of the Pax6-dependant molecular mechanism in
mammalian corticogenesis
The model is based mainly on results of the cortical phenotype of Pax6cKO mutant
postnatally in this study, and published data for the Sey/Sey embryos (Tarabykin et
al., 2001; Zimmer el al., 2004; Schuurmans et al., 2004). Initially the NE cells (black)
divide symmetrically that leads to an increase in the germinative pool of the pallium.
Around E12.5 in mouse, a substantial portion of NE cells start to transform into radial
glia (RG) pluripotent progenitors that can generate both, neuronal and glial cells
(Heins et al., 2002). More than 90% of the early RG cells (E12-E14) express Pax6 at
a high level as intrinsic determinant of their fate (Götz et al., 1998). The RG cells
divide both symmetrically and asymmetrically at the apical surface of the VZ,
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generating both IGL neurons and intermediate progenitors (IP), also named basal
progenitors (BPs) (see also Fig.5). These IPs undertake symmetrical division at the
basal surface of VZ forming after E13.5 the SVZ, a second proliferative zone of the
cortex that produces exclusively SGL neurons (reviewed by Kriegstein et al, 2006).
Expressed at a high level in the early RG progenitors, Pax6 controls the specification
of sub-lineages of IGL neurons by a direct transcriptional control on the expression of
the IGL determinant genes Ngn2 (for L6, L5; Scardigli et al 2003; Schuurmann et al.,
2004) or Er81 (for L5, this work) in a region restricted manner. Our present results
further show that Pax6 is involved in determining the neuronal outcome of some IGL
sub-lineages (e.g. for Clim1a+, Fezl+, Smi32+, Lmo+4, NSE+ L5 neurons) or their
migratory ability  (e.g. for Vglut1+, Clim1a+, Lmo3+, Lmo4+, Fezl+, Slap1+, NSE+).
The available data allows to assume that while the first effect, including Pax6-
dependent, direct control on the cell cycle parameters of IGL sub-lineages, the
migratory deficiency affects neuronal subpopulations that are specified in a
Pax6—Ngn2 dependent pathway in a region specific manner (mostly in the
rostrolateral cortex). At late developmental stages (after E14.5), the diminished pools
of RG progenitors is misspecified and fail to produce both correctly specified IP in the
SVZ and SGL in absence of Pax6 (this work, Tarabykin et al., 2001; Nieto et al.,
2001). Pax6 is expressed at low level in the late RG progenitors and only transiently
in the IPs suggesting that Pax6-dependent program might specify environmental
cues that determine the fate of the SGLs in IPs. Furthermore, the widely documented
molecular ventralization of the NE at the PSPB (Stoykova et al., 1996;
2000;Toresson et al., 2000; Yun et al., 2001; Muzio et al., 2002; Kroll and O´Leary,
2005) leads to the massive invasion of GABAergic INs into the pallial SVZ prior to the
SGL formation in the Pax6 mutants possibly contributing to the inhibition of
proliferation of the late progenitors in the SVZ (Haydar et al., 2000; Liu et al., 2005),
thus hampering in addition the acquisition of the late neuronal cell fate.   Another
possibility is that the low level of Pax6 in the late RG progenitors might regulate
specific sets of still not identified determinants for acquiring of the IGL cell fate. CP,
Cortical plate; bVZ, Basal ventricular zone; IZ, Intermediate zone; MZ, Marginal zone;
PPL, Preplate; VZ, ventricular zone;
The first conclusion from our analysis of the cortical phenotype in
Pax6cKO mice is that Pax6 has an intrinsic role in the specification of SGL
neurons. Previous analyses of Sey/Sey embryos suggested the involvement
of Pax6 in the formation of SGL (Schmahl et al., 1993; Caric et al., 1997;
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Schuurmans et al., 2004) and data from BrdU labeling and transplantation
experiments suggested migration defects as a possible reason for the mis-
building of SGLs in Sey/Sey cortex CP (Caric et al., 1997). The fact that
Pax6cKO mice reach adulthood helped us to gain a more definitive answer to
this important question. Our expression analysis showed a complete or almost
full loss of the expression of molecular markers for SGL neurons in Pax6cKO
cortex (Fig.9). However we did not observed any mis-allocation or an ectopic
expression of correctly molecularly specified SGL neurons in the postnatal
Pax6cKO cortex (Fig.9, see discussion below). Furthermore, the expression
analysis at stage E17.5 and P10 revealed severe expression gaps in the
rostral mutant cortex for Id2 and Lhx2, two factors strongly expressed in the
SGL neurons, suggesting a deficit in the generation of these SGL neuronal
lineages (Fig.9G/J´). In addition, BrdU labeling at two stages during
generation of the SGL (E16.5 and E18.5), revealed almost a complete loss of
upper cortical neurons in the Pax6cKO cortex at P10, and an enhanced
number of BrdU+ cells within the enlarged VZ/SVZ of the mutant.
Interestingly, however these preserved progenitors seemed to have the
capacity to produce enlarged sets of olidodendrocytes and INs, possibly even
after birth (Fig.13). Thus, when Pax6 is not functional, the SGL neurons are
absent not because of migratory defects or a delay of the RG differentiation,
but because of a failure in the specification of the late RG that leads to the
generation of SGL neurons. We conclude therefore, that Pax6 has a pivotal
role in initiating differentiation of the late RG towards SGL neuronal cell fate.
Intriguingly evidence has been proposed that, the neurons of SGLs appear to
be selectively activated in the process of remote memory recall (Frankland et
al., 2004). In line with this, a selective deficiency in remote memory recall was
observed in Pax6cKO mice (Raduschkin and Stoykova unpublished data).
The early RG cells generate the majority of the lower cortical layers and the
BPs/IPs located in the SVZ. This second proliferative zone is evident after
E12.5 in the mouse and is assumed to generate predominantly upper cortical
layer neurons  (Fig.5; Fig.21; Noctor et al., 2004; Haubensak et a., 2004;
Tarabykin et al., 2001; Zimmer et al., 2004). During early corticogenesis the
pluripotent RG progenitors in the pallial VZ express Pax6 at a high level,
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which progressively declines after stage E15.5 (Walther and Gruss, 1991;
Stoykova et al., 2000). The low expression level of Pax6 however seems
important for specification of the late RG cells. In fact the forced elevation of
the Pax6 expression level in cortical progenitors in transgenic mice causes
much more profound diminishing of the upper, when compared with the lower
layer neurons (Berger et al., 2007; Manuel et al., 2007).
Another possibility might be that Pax6 plays an essential role in
formation of the second germinative zone of the pallium, the SVZ. As recently
suggested, progenitors of the SVZ might play a pivotal role in the generation
of the most of the upper layer neurons (Tarabykin et al., 2001). Pax6 is
expressed only transiently in a subpopulation of BPs in the SVZ (Englund et
al., 2005), but it seems to be required for their proper specification, possibly
by controlling the expression of neuronal identity genes. The present
understaanding suggests that Cux1/2 (Nieto et al., 2004; Zimmer et al., 2004),
Svet1 (Tarabykin et al., 2001), and Tbr2 (Englund et al., 2005; Quinn et al.,
(2006), genes that are specifically expressed in both BPs in SVZ and in SGL
neurons in Pax6-dependent manner and are possible candidates to play a
role in this process.
Our analysis discovered a novel role of Pax6, namely involvement in
determination of migratory ability and the neuronal output of several
subpopulations of IGL neurons. We found  (mostly in the rostral cortex) that
several subpopolations of IGL neurons  (Vglut1+, Clim1a+, Lmo3+, Lmo4+,
Fezl+, Slap1+, NSE+) have correct molecular specification but are mis-
allocated to a lower than normal position in the CP and/or ectopically
distributed in GE of the HiSVZ and pPv in the Pax6 mutant. Similarly,
migratory defects of IGL neuron subtypes have been reported in the Ngn2
mutant and Ngn2/Ngn1 double mutant (Schuurmans et al., 2004). Given that
Ngn2 acts as a direct downstream of Pax6 in the corticogenesis (Scardigli et
al., 2003), these findings suggest possibly that a Pax6-Ngn2 dependent
mechanism modulate the migratory property of these IGL cell lineages.
Moreover we observed an enhancement in the pool size of IGL
neuronal sub-lineages (Clim1+, Lmo4+, Fezl+, Smi-32+). The preformed
BrdU-birthdating analysis during late developmental stages (E16.5 when the
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SGL are born) with ISH for early-born L5 neuronal markers (Fezl, Clim1a)
excluded the possibility that the RG progenitors keep producing early IGL
neuronal fate at late developmental window. Thus, we assume that while
expressed at a high level in the early RG progenitors, Pax6 could control the
neuronal output of IGLs, possibly regulating the mitotic parameters of IGL
neuronal sub-lineages. This is in accordance with previous data indicating that
only the early progenitors exhibit defects in their proliferative properties in
Sey/Sey embryos (Gotz et al., 1998; Estivill-Torruset al., 2002). Furthermore,
in chimeric Pax6-/-; Pax6+/+ brain, a bigger proportion of the Pax6-/-
progenitors exit from the mitotic cycle early in development, leading to a
diminished progenitors pool for late neurogenesis (Quinn et al., 2006).
Given that progenitors in the pallial VZ generate the majority of IGL
neurons, transcriptional factors expressed both in VZ progenitors and IGL
neurons such as Er81 are candidates for instructive factors for specifying IGL
neuronal fate. Similarly as for Ngn2, we demonstrated in this study that Pax6
directly regulates the expression of Er81 only at high dosage both in vitro and
in vivo.  Accordingly, we show that in the absence of Pax6 function the
expression of Er81 is severely affected in the ventrolateral VZ and CP at the
mid-gastation stage as well in L5 of the parietal cortex at the postnatal stage.
This supports the idea that Pax6 regulates the specification of subpopulations
of IGL neuron by controlling the instructive factors of these neuronal subtypes.
Previous data indicated that in absence of Pax6, the pallial progenitors
are progressively ventralized, acquiring ectopic expression of subpallial
markers that causes a partial transformation of the glutamatergic pallial into
the fate of subpallial progenitors, generating GABAergic INs (Stoykova et al.,
2000; Toresson et al., 2000; Yun et al., 2001 Kroll and O´Leary, 2005). As a
novel characteristic of this phenotype we demonstrated here that during
development Er81 exhibits ectopic and enhanced expression in the pallial
SVZ/IZ obviously connected with the olfactory bulb. Furthermore, the enlarged
SVZ of the forebrain at rostralmost level seems to generate more GAD65+
and Calbindin+ INs, invating the PFC and Fr cortex of the mutant possibly
even postnatally. It is interesting to note that GABA signaling is emerging as
an essential signaling in modulating progenitor proliferation in the VZ/SVZ of
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cortex (Haydar et a., 2000; Liu et al., 2005). It fits well with the reported
increased numbers of cycling cells in SVZ of the Pax6 mutant (Toresson et
al., 2000 and Yun et al., 2001). Therefore the widespread ventral
misspecification, leading to ectopic GABA signaling in VZ/SVZ in the Pax6
mutants may determine or contribute to the loss of SGL neurons. We found
that the most severely affected domain of the Pax6cKO cortex at adulthood is
the frontal cortex, which contains an enlarged set of INs, IGL neuronal
subpopulation, but completely missing SGLs. The medial PFC, the frontal,
and the cingulate cortices integrate information from the sensory, motor, and
limbic areas (Uylings et al., 2003; Miashita, 2004) and such integrative
function of PFC appears to be essential for remote memory recall (Maviel et
al., 2004). In fact Pax6cKO mice showed that the PFC and Fr cortex are the
most severely affected regions in Pax6cKO brain in which the SGL are
abrogated. MRI studies on Aniridia patients also revealed a reduced gray
matter (especially of the anterior cingulate cortex), a dysgenesis of corpus
callosum, and absence or hypoplasia of anterior commissure  (Ellison-Wright
et al., 2004; Sisodiaya et al., 2001). We also found these defects in the
Pax6cKO mutant (Fig.14). Thus, anatomical defects and related behavior
deficits of mutant brains are similar to those of Aniridia patients suggesting
that the cortex specific Pax6cKO mouse line is an ideal model to study
aspects of this inherited disorder of humans.
3.2 Pax6 in cortical arealization
Previous studies demonstrated that the frontal cortex of Sey/Sey embyo is
diminished and molecular markers for caudal cortical domains expand
rostrally, implicating Pax6 in the acquisition of cortical area identity (Bishop et
al., 2000, 2002; Muzio et al., 2002). The severe dysgenesis of the
diencephalon in both Sey/Sey (Stoykova et al., 2000, Hevner et al., 2000) and
conventional Pax6KO (Jones et al., 2002) embryos hampered so far the study
of cortical area identity in these mutants. However, in the cortex-specific
Pax6cKO these investigations became possible. Our results indicate that the
frontal cortex in the Pax6cKO is also diminished and mispatterned, the SGLs
including layer 4 are severely underrepresented, and there is a rostral shift of
caudal borders along the AP axis of the neocortex (Fig.16A/D´). Surprisingly,
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however, the TCA and CTA projections from the M, SS and, Vi domains with
the correspondent sensory nuclei of thalamus were preserved, indicating that
cortical area identity is largely unaffected in a lack of Pax6 in the pallial
progenitors (Fig.16E/F´). This is in line with recent results from Pax6 gain-of-
function experiments with PAX77 YAC transgenic mice, carrying several
copies of human PAX6 , that showed also a normal thalamocortical
connectivity (Manuel et al., 2007). It is generally assumed that establishment
of topographic projections is regulated by cues located within developing
cortex (such as COUP-TF1 and Emx2 with a regionalized expression in
occipital cortex and intermediate structures as internal capsule (Bishop et al.,
2000, Zhou et al., 2001).  Similarly to Pax6cKO mice, FGF8 hypomorphic
mutants display molecular caudalization of the rostral cortex with apparently
normal thalamocortical connectivity (Garel et al., 2003). Furthermore, the Ebf1
and Dlx1/2 double KO mice demonstrate thalamocortical shift without gene
expression shift (Garel et al., 2002), while in Mash1 and Gbx2 KO mice where
early thalamocortical projections do not reach to the cortex, embryonic cortical
gene expression patterns are not affected (Miyashita-Lin et al., 1999;
Nakagawa et al., 1999). Together with our new finding for Pax6cKO, these
results support the view that that molecular regionalization and thalamic
connectivity are possibly not strictly interdependent processes (Garel et al.,
2002).
3.3 Pax6 in neurogenesis of the adult hippocampus
We were very much intrigued by the fact that the CA1-CA3 regions of the
hippocampus in Pax6cKO mutant contained enlarged set of pyramidal cells at
adulthood. Moreover, Hi in the mutant appeared to have more progenitors-like
(Nestin+ cells in str. or) and newborn neurons (PSA-NCAM+ in the ammon
horn). Although this phenotype is not a subject of a detailed analysis in the
present study, these interesting findings deserve attention.
Previous studies revealed that in the hippocampus, glutamatergic
pyramidal cells and cortical GABAergic INs are divergent in both their sources
of genesis and their mode of migration. Hippocampal pyramidal neurons are
known to originate from distinct components, constituting the hippocampal
neuroepithelium (HiSVZ) at the embryonic stage and from a few precursor
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cells in the subgranular layer (SGL) of the dentate gyrus, which are able to
generate new granule neurons even at the adult stage (reviewed by
Kempermann et al., 2004; Liedo et al., 2006). Hippocampal pyramidal
neurons also originate from the neuroepithelium in VZ of the dorsal
telencephalon, especially from the posterior periventricular zone (pPv), from
where they migrate to distinct hippocampal regions (Nakatomi et al., 2002). In
contrast to hippocampal pyramidal neurons, the origin of hippocampal INs is
still under debate (Kempermann et al., 2004; Liedo et al., 2006). The current
view of neurogenesis assumes that the generation of new neurons occurs at
low levels in several neurogenic niches in the adult brain (Gross, 2000,
Alvarez-Buylla & Lim et al., 2004; Liedo et al., 2006). Developmental signals
like Notch, BMPs, Eph/ephrins, Nogging and Shh seem to play important
roles in maintaining adult neurogenic niches (reviewed by Alvarez-Buylla and
Lim, 2004; Liedo et al., 2006). Recently Wnt and GABA signaling were shown
as determinants for various processes during the development, including
proliferation, differentiation and maturation of stem cells and their progeny
(Kleber and Sommer, 2004; Ge et al., 2007; Jagasia et al., 2006; Tozuka et
al., 2005). Several genes encoding for components of the Wnt signaling such
as Wnt3, Wnt7, Fz3, Dvl1 express in the dentate gyrus or coexpress with the
neural stem cell marker, GFAP (Lie et al., 2005; Maekawa et al., 2005).
Recently Lie et al (2005) demonstrated both in vitro and in vivo that the forced
expression of Wnt3  is sufficient to increase neurogenesis from adult
hippocampal progenitors. By contrast, the blockage of Wnt signaling led to the
abolishment of neurogenesis in this sub-region.
Thus, several reasons for the observed enhanced presence of
pyramidal neurons in Hi of the adult Pax6cKO cortex should be considered.
Previous data indicates that Wnt8 and Wnt3a, two factors known to promote
Hi morphogenesis (Galceran et al., 1999; Lee et al., 2000), are overexpressed
in the caudomedial cortical primordium in Sey/Sey leading to an expansion of
the caudomedial pallium, including the hippocampal anlage (Muzio et al.,
2002a). Interestingly, results from MRI indicate a local excess of gray matter
volume in Hi from Aniridia patients (Ellison-Wright et al., 2004). Indeed, we
found at P10 that the subiculum and the Ammon horn of Pax6cKO contain a
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surplus of Vglut1+, NSE+, and Smi-32+ pyramidal neurons. Most intriguingly,
we observed that the Hi of the adult brain is not only augmented, but the str.
oriens is abundantly populated by Nestin+ cells, and the CA1-CA3 and DG
contain enhanced numbers of young differentiating PSA-NCAM+ neurons.
Judged by the enhancement of Smi-32+ pyramidal neurons with extensively
branched processes, such young neurons appear to differentiate successfully
at maturity in the mutant Hi. In adult brain Pax6, Emx2, and Mash1 are
expressed in distinct small subpopulations of progenitors in the subgranular
layer of DG, HiSVZ and pPv, regions considered to be the neurogenic zones
of the adult brain (Gross, 2000, Alvarez-Buylla & Lim et al., 2004; Liedo et al.,
2006).  We do not know the consequences of the functional ablation of the
function of Pax6  on the expression of Emx2 and Mash1  in pPv of Hi.
However, our present results allow us to suggest that after birth, a set of
newly generated neurons in pPv and/or HiSVZ possibly invade DG and Hi in
the Pax6cKO. It is conceivable that the addition of new neurons into the
already established hippocampal circuits of the adult brain could disrupt
specifically Hi-dependent cognitive functions (McClelland et al., 1995). Indeed
the Pax6cKO mice show a specific defect in contextual recent memory recall
(Raduschkin and Stoykova unpublished data)
3.4 Trim11 controls the stability of Pax6
It is becoming clear that transcription factors do not act alone but are
dependent on interactions with other proteins in order to fulfill fully their
physiological function. These interactions modulate the specificity and
regulatory function of the transcription factors on their targets. Previous
evidence demonstrated direct interactions of Pax6 with the transcription factor
Sox2 on the lens-specific enhancer element of the -crystallin gene (Kamachi
et al., 2001); Cdx-2/3 and p300 on the G 1 promoter element of the
proglucagon gene (Hussain et al., 1999); transcription factor Maf on the
glucagons promoter; AP-2 on the gelB promoter in the corneal epithelium
(Sivak et al., 2004). The biochemical dissection of the Pax6 domains had
shown that both PD and HD bind to DNA in a specific manner (Fig.7; Epstein
et al., 1994b; Czerny et al., 1995; Kozmik et al., 1997; Jun et al., 1998).
However, the regulatory elements of almost all identified target genes for
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Pax6 binds to the PD of Pax6 (reviewed by Simpson & Price, 2002), while
most of the reported Pax6 protein partners bind to the HD or at least to
regions out of the PD of Pax6 (Kamachi et al., 2001; Hussain et al., 1999;
Planque et al., 2001a,b; Tominaga et al., 2002; Cvekl et al., 1999; Sivak et al.,
2004). This raises the possibility that Pax6 exerts its physiological function by
using the PD and HD preferably for DNA-binding or protein-protein binding,
respectively.  In this line of evidence recent analyses of transgenic mice with
specific defects in PD or HD of Pax6 revealed that these Pax6 domains
contribute differentially to brain development (Haubst et al., 2004).
Furthermore numerous C-terminal Pax6 mutations have been described in
patients with different developmental anomalies (Ellison-Wright et al., 2004;
Heyman et al., 1999; Singh et al., 2001; Sisodiya et al., 2001; Mitchell et al.,
2003). The interaction between Pax6 and its recently identified partners,
Homer3 and Dncl1, is ablated by such C-terminal Pax6 mutations (Cooper &
Hanson, 2005). Therefore some of the developmental malformation in
patients with Pax6 mutations could be explained by disrupted protein-protein
interactions.
Given the neurogenic function of Pax6 for RG progenitors (Heins et al.,
2002) and its important role in the generation of neurons with distinct neuronal
fate as described in this work, one of our goals was to identify
Pax6–interacting partners that modulate the neurogenic role of Pax6 during
corticorgenesis. By above objectives, we used mouse Pax6 cDNA, lacking a
fragment encoding for the PD (Pax6PD) to screen a cDNA library made from
isolated E15.5 mouse cortex (Fig.17A). Out of 116 independent positive
colonies, sequences of four corresponded to the cDNA sequence of Trim11.
During the progression of this study, Cooper & Hanson (2005) presented
preliminary data for the identification of Pax6-interacting partners using the
cDNA library of the mouse adult brain with Pax6-PST and Pax6-CTP,
containing the whole PST domain (amino acid residues 278-422) and the C-
terminal peptide (amino acid residues 391-422) from the human Pax6 cDNA.
Trim11 is one of the potential Pax6-interacting partners (Cooper & Hanson,
2005).  We verified that Trim11 indeed interacts with Pax6 by utilizing different
biochemical approaches such as the pull-down, immunoprecipitation assay
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and cellular colocalization analysis  (Fig.17 and 18).  Trim11 acts as an E3
ligase and regulates the intracellular level of Humanin, a peptide with
neuroprotective activities against Alzheimer ´s disease (Niikura et al.,
2003). Our results indicate that Pax6 is another substrate for the E3 ligase
activity of Trim11 (Fig.18). Firstly, the co-expression of Trim11 and Pax6 in
Hela cells and the overexpression of Trim11 in cortical primary cells
drastically reduce the stability of Pax6 protein. Secondly, Trim11 catalyzes the
reaction responsible for forming the Ub-conjugated Pax6. Thirdly, treatment of
Trim11 and Pax6-expressing cells with a proteasome inhibitor significantly
inhibits the Trim11-mediated degradation of Pax6.
In addition to the common role that E3 ubiquitin ligases play in the
degradation pathway, various members of Trim/RBCC family has shown more
complex functions, such as those involved in epigenetic control,
gene–silencing or control of transcription (Meroni & Diez-Roux, 2005; Hirose
et al., 2003; Le Douarin et al., 1996; Shimono et al., 2000; Friedman et al.,
1996; Cammas et al., 2000; Peng et al., 2002; Wang et al., 2004). By using
gain-of-function experiments in cortical primary culture, we showed a
corresponding decrease of the Pax6 protein level which is not due to
transcriptional regulation of Pax6 and Pax6(5a) mRNA. Thus, our present
data demonstrate the exclusive role of Trim11 in controlling the stability of
Pax6 protein in cortical progenitors.
There is increasing evidence about the important role of UPS in cortical
neurogenesis. Several molecules that are important in this developmental
process such as P35, Dab1 and Notch are substrates of UPS (Arnaud et al.,
2003; Bock et al., 2004; Patrick et al., 1998; Qiu et al., 2000). Recent analysis
revealed that knocking-out the function of UBR1 and UBR2, E3 ubiquitin
ligases of N-end rule pathway, causes impairment of neurogenesis (An et al.,
2006). In addition, Ubiquitin C-terminal hydrolase L1 affects the morphology of
the neural progenitor cells and modulates their differentiation (Sakurai et al.,
2006). We found that the overexpression of Trim11 not only mediates the
degradation of Pax6 protein, but also inhibits specifically the neurogenic role
of Pax6.
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3.5 The expression level of Pax6 and Trim 11 possibly
involves an autoregulatory feedback loop
Collective data from functional studies on Pax6 has highlighted the fact that
different levels of Pax6 play essential roles in different aspects of mammalian
development. Thus, homozygous Sey/Sey mouse embryo have no eyes,
whereas the obvious defects in the heterozygous (Sey/+) embryos are the
smaller eyes with various ocular abnormalities, suggesting that the function of
Pax6 depends on a defined threshold (Hill et al., 1991). Accordingly,
transgenic mice carrying multiple copies of human Pax6 on a WT background
show similar phenotyes to the Sey/Sey ocular abnormalities  (Schedl et al.,
1996). Thus, the level of Pax6 in the developing eye is crucial, with both
reduced and increased gene dosages, causing profound developmental
defects in this organ. Also in developing cortex, the difference of the
spatiotemporal expression level of Pax6 seems to play specific roles. Thus,
abolishment of the rostral-high to caudal-low expression gradient of Pax6 in
the cortical progenitors results in severe shrinkage of the rostral cortex
specifically (Bishop et al., 2000, 2002; Muzio et al., 2002). Similarly, the high
expression level of Pax6 in progenitors of VP and LP is important for the
specification of several amygdalar nuclei that originate from these restricted
progenitors domains (Tole et al., 2005).
 Pax6 is a neurogenic factor for cortical progenitors (Heins et al., 2002)
expressed at a high and low level in the early and late progenitors,
respectively. It appears to regulate different aspect of corticogenesis, as
shown in this present study. It is interesting to note that both, the Pax6 loss-
of-function (this work) as well as Pax6 gain-of-function in cortical progenitors
(Berger et al., 2007, Manuel et al., 2007) indicated that the specification of
SGL neurons is more severely affected. Together, the available data suggest
that the maintenance of the correct level of Pax6 in distinct cortical domains
and at different time windows has a pivotal role in correct neurogenesis.
Both biological and non-biological studies have shown the
establishment of auto-regulatory feedback loops between developmental
regulators is important in many systems (Hasty et al., 2002). In living cells,
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transcriptional factors and UPS show a “cross-talk” through the formation of
an auto-regulatory feedback loop which balance their activities (Wu et al.,
1993; Leng et al., 2003). Our results strongly suggest that Trim11, an E3
ligase for Pax6, functions as a negative regulator of Pax6 expression in
cortical progenitors. Although further work is necessary to confirm whether
Pax6 could directly activate the expression of Trim11, we suggest that Pax6
and Trim11 possibly participate in an autoregulatory feedback mechanism,
that regulating their expression levels and activities during corticogenesis (see
the schema in Fig.20)
Thus our results demonstrate for the first time that the expression of
Pax6 is not only regulated at transcriptional level, but also includes post-
translational modifications involving the ubiquitin-proteosome system. The
data further implicate that Trim11 as being a modulator, thus contributing to
the establishment of the correct physiological function of Pax6 transcription
factor during mammalian corticogenesis.
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4. Summary
Pax6 is a key transcription factor involved in the organogenesis of the eye,
pancreas, and brain. In developing cortex, Pax6 has been implicated to play a
role in regionalization, neurogenesis, layer formation, and axonal path finding.
Mice deficient for Pax6 die before these processes are accomplished, having
multiple brain defects, thus precluding further studies on the consequence of
Pax6 deficiency on cortical layering, arealization, and brain function. To
determine roles of Pax6 in these key events of cortical patterning, we
generated a Pax6 conditional knockout mouse (Pax6cKO) that reachs
adulthood, in which the function of Pax6 is ablated at the onset of
corticogenesis only in the radial glia (RG) or cortical progenitors. We show
that deletion of Pax6 specifically abrogates the differentiation of the late RG
progenitors into upper cortical layer neurons. Instead, the RG cells
accumulate in an enlarged pool along the corticostriatal border overproducing
interneurons and oligodendrocytes. Furthermore we found that Pax6 function
is essential for the normal output of correctly specified subpopulations of the
lower cortical layer neurons and their migratory ability. Moreover, we present
evidence that Pax6 directly regulates the expression of the transcription factor
Er81 in layer 5 neurons. In the absence of Pax6, there is a rostral shift of
caudal molecularly defined borders across the AP axis of the cortex, however
the area identity and the major connectivity patterns are surprisingly normal.
Many morphological defects of mutant brains displayed are similar to those of
Aniridia patients, suggesting that the cortex specific Pax6cKO mice might be
helpful to study aspects of this genetic disorder in humans.
Given the essential role of Pax6 in neurogenesis, we attempted to
study mechanisms regulating Pax6 activity in the developing cortex. We
searched for proteins interacting with Pax6 by using the yeast two-hybrid
screen approach and found that Trim11 interacts with Pax6. Our analysis
indicates that Trim11 regulates the intracellular Pax6 level through the
ubiquitin-proteasomal degradation pathway. Accordingly, we show that
overexpression of Trim11 causes inhibition of neurogenesis due to the
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degradation of Pax6. Our results further indicate that Trim11 might participate
in an autoregulatory feedback loop that controls Pax6 function.
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5. Materials and Methods
5.1. Oligos, antibodies, plasmids and animals
5.1.1. Oligos
PCR primers for PCR, qPCR, ChIP, EMSA were ordered from IBA (Göttingen,
Germany) and Qiagen (Hilden, Germany). The name, sequence (or catalog)
and usage of oligos are described in table 2.
Oligo name Sequence (5´3´) or catalog number (Qiagen) Usage
ChIP/Con/F CCGTCTCTTTAGTCCCGTTAGGTGAAA ChIP
ChIP/Con/R GCTCTTGCATTTGCATAGCTAATTACCCT ChIP
ChIP/P6/81F CTTTTCTCTACCTTTGACCCGGAGTCCA ChIP
ChIP/P6/81R CCTCTCAGCACTCTCCAGGATGAATCT ChIP
E/P6/Er81 TAGAAGCAGCTTCTCCCGCTTGCTTTCCTTACAATAT EMSA
E/P6/Er81/M TAGAAGCAGCTTTTCCCGAGTGCTTTCCTTACAATAT EMSA
E/P6/Cons AATTTTCACGCTTGAGTTCACAGCT EMSA
E/P6/Trim11a TAATAATAAATCTTTAGGCCAGAGTGAGCAGGGACTG EMSA
E/P6/Trim11b TGCACACAAATCAGTGAAAGATGAGTCTTTGCTCTTT EMSA
E/P6/Trim11c GGCCGCTGCAGACGCAGGCTGGAGTGCGTTCCGGCTC EMSA
E/P6/Trim11d TCTGAGCAGCTCAGGGCTGCCTGTAACTCCAGCTGTA EMSA
E/P6/Trim11e ACTTTGATGTGCATTGGAGGGAGACATTCAAACTGTA EMSA
E/P6/Trim11f AGTGGGGTGTTCAGAGATGAGTGAAGACAGAAGCCCG EMSA
E/P6/Trim11g GAGACCTCCATCTTCTCCCATGTTCTCACCCGTCACT EMSA
E/P6/Trim11h CTAGGGGTACTTACTTAAGCCTGAGGCTCCAACAGCC EMSA
q18S QT01036875 QPCR
qPax6(5a)/F CACAGCGGAGTGAATCAGCTT QPCR
qPax6(5a)/R GCACCTGGACTTTTGCATCTG QPCR
qPax6/F CCTGGTTGGTATCCCGGGA QPCR
qPax6/R CCGCTTCAGCTGAAGTCGCA qPCR
qTrim11/F GCAGAAATGGCACGACGCCT qPCR
qTrim11/R GGAACAGCATTGCGTCCTCCA qPCR
Table 2. List of oligos
5.1.2. Antibodies
The name, origin, host, source and dilution of antibodies are described in
table 3.
DilutionName Origin Host Supplier
IHC/ICC WB
Primary Antibody
Calbindin Human Rabbit Dako 1:2500
Calretinin Human Mouse Dako 1:2000
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Cre Peptide Rabbit Covance 1:1000
Er81 Chick Mouse DSHB 1:3000
GAD67 Mouse Mouse Sigma 1:2000
GFAP Peptide Mouse Chemicon 1:100
GFP Peptide Mouse Chemicon 1:500
GST Peptide Mouse Zymed 1:500
HA Peptide Rat Roche 1:50 1:500
His Peptide Mouse Novagen 1:1000
Luciferase Peptide Goat Abcam 1:100
Nestin Peptide Mouse Chemicon 1:300
NeuM Peptide Rabbit Chemicon 1:300
Pax6 Chick Mouse DSHB 1:300 1:500
Pax6 Peptide Rabbit BABCO 1:300 1:1000
PSA-NCAM Peptide Mouse Chemicon 1:100
Smi-32 Peptide Mouse Sternerberger 1:2500
ß-Actin Peptide Rabbit Sigma 1:1000
Tuj Peptide Mouse Chemicon 1:200
Secondary antibodies (peroxidase-conjugated)
IgG Rabbit Goat Covance 1:10000
IgG Mouse Goat Covance 1:5000
IgG Rat Goat Covance 1:10000
IgG Mouse Goat Bio-Rad 1:5000
Secondary antibodies (Alexa)
Alexa 488 Rabbit Goat Molecular Probe 1:400
Alexa 488 Mouse Goat Molecular Probe 1:400
Alexa 568 Mouse Goat Molecular Probe 1:400
Alexa 568 Rabbit Goat Molecular Probe 1:400
Alexa 594 Chick Goat Molecular Probe 1:400
Alexa 594 Rabbit Goat Molecular Probe 1:400
Alexa 594 Mouse Goat Molecular Probe 1:400
Alexa 594 Rat Goat Molecular Probe 1:400
Table 3. List of antibodies
5.1.3. Anti-sense probes for ISH
The name, preparation (linearization, transcription of plasmid templates) and
source of anti-sense probes for ISH are described in table 4.
Probe preparationGene
RE Polymerase
Source
Arx HindIII T3 Lab stock
Cad-8 HindIII T3 Lab stock
Clim1a SalI T7 I. Bach
Cux2 XbaI T3 J. Liu
Dlx1 XbaI T3 M. Price
EphA4 EcoRI T7 R. Klein
ER81 ApaI SP6 V. Tarabykin
Gad67 XhoI T3 Lab stock
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ID2 SalI T3 R. Benezra
Lhx2 NotI T7 G. Bernier
Lmo3 EcoRI T7 B. Anderson
Lmo4 SacI T3 B. Anderson
Msi1 SacI T3 H. Okano
Oligo2 EcoRI T7 D. Anderson
Otx1 EcoRI SP6 Lab stock
PLP/DM20 BamHI T3 Lab stock
RzR-ß EcoRI T3 C. Kaznovski
Slap1 EcoRI T3 Lab stock
Tbr1 HindIII T3 J. Rubenstein
Vglut1 EcoRI T3 Lab stock
Table 4. List of anti-sense probes for ISH
5.1.4. Plasmids
The name, insert, backbone vector, references for plasmids are listed in table
5. All plasmids generated in this study are described in detail below.
Name Insert Backbone vector Reference
Pax6PD Pax6PD pBDLeu (Invitrogen) This study
CMV-Pax6 Pax6 PCMV Walther and Gruss,
1991
Flag-Pax6 Pax6 pCS2-MT Lab stock
GST-Trim11 Trim11 pGEX (Pharmacia) This study
HA-Trim11 Trim11 pHA-CMV (Clontech) This study
Er81-Luc Er81
promoter
pGL3 (Promega), This study
Er81Cre Er81
promoter
Cre backbone This study
PSP64-Pax6 Pax6 PSP64 Marquardt et al., 2001
CMV-Gfp Gfp CMV-Gfp (Clontech)
Ubi-His Treier et al., 1994
Table 5. List of plasmids
5.1.5. Animals
Small-eye (Sey), Pax6 flox and Emx1Cre, NexCre, Er81Cre JoP6 mice were
maintained in a C57BL6/J background. Cortical primary cells were derived
from the mouse strain CD1. Chick eggs were ordered from Lohmann Animak
health GmbH (Cuxhaven, Germany).
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5.2. Methods for DNA study
5.2.1. Standard polymerase chain reaction and genotyping
Primers were designed with length around 20-26 nucleotides with Tm=55-
60°C. The reaction mixture contained 1 l template DNA (10 pg-1 ng plasmid
DNA, or 200 ng genomic DNA), 1 l 10 pmol/l forward primer, 1 l 10 pmol/l
reverse primer, 1x PCR Buffer, 4-8 l 2.5 mM dNTPs, and 0.5 l Taq
Polymerase (5U/l) in a total volume of 30 l. The thermocycling program
(Table 6) was carried out using PTC-200 thermal cycle (Perkin Elmer).
Step Temperature Duration
1. Initial denaturation 94 °C 4 minute
2. Denaturation 94 °C 30 seconds
3. Annealing 50-55 °C 30 seconds
4. Elongation 72 °C (About 1 minute/kb)
5. Go to step 2, repeat 29 to 39 times (30-40 cycles)
6.Final elongation 72 °C 10 minutes
7. Incubation 4 °C Unlimited
Table 6. The thermocycling program for a standard polymerase chain reaction
(PCR)
5.2.2. Purification of PCR products
PCR products were purified using QIAquick PCR Purification Kit (Qiagen) as
described by the manufacturer.
5.2.3. DNA electrophoresis and purification from the agarose gel
0.5-2% agarose gel was prepared by melting agarose (Invitrogen) in 1x TBE
Buffer (90 mM Tris-borate, 2 mM EDTA, pH 8.0) and subsequently adding
ethidium bromide to a final concentration of 0.3 g/ml. DNA sample was
mixed with 5x DNA loading buffer (25% Ficoll, 100 mM EDTA, 0.05%
Bromophenol Blue), and electrophoresis was performed under 1-7 v/cm in
1xTBE buffer. For fragment purification, the band was excised from the gel.
DNA was extracted using QIAquick Gel Extract Kit (Qiagen) as described by
the manufacturer.
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5.2.4. DNA digestion with restriction enzymes
1-10 g DNA was incubated with 20-80 U of the approate restriction
enzyme(s) at 37°C for 2 hours or overnight. For end-cutting of the PCR
product, crude PCR product was purified with a PCR Purification Kit (Qiagen)
and then incubated with 30-60 U restriction enzyme(s) at 37 °C overnight.
5.2.5. Dephosphorylating or blunting the ends of DNA fragments
Dephosphorylation of DNA 5’-end was performed by directly adding 1 l
Alkaline Phophatase (1U/l, Roche) into the restriction enzyme digestion
mixture and incubating at 37 °C for 1 hour.
DNA polymerase I large fragment (Klenow fragment) (5U/l, NEB) was used
to fill-in the ends of overhang-5’ DNA fragment. DNA in restriction enzyme
NEB buffer supplemented with 33 M dNTPs was incubated with Klenow at a
concentration of 1U per g DNA at 25 °C for 30 minutes.
3’-overhang DNA fragment was made blunt using Pwo DNA Polymerase
(5U/l, Roche), 0.5 l of which was mixed with 5 l 10x conc. PCR buffer with
20 mM MgSO4 (Roche), 0.5 l 20 mM dNTPs, 4 l H2O, and 40 l DNA
fragment in a total volume of 50 l, then incubated at 72°C for 15 minutes to
achieve the reaction.
5.2.6. Ligation
25-100 ng purified vector fragment was mixed with a 5 fold excess (molecular
ratio) of purified insert fragment, 1x T4 DNA ligase buffer (MBI Fermentas),
and 1 l T4 DNA ligase (3 U/l) (MBI Fermentas) in a total volume of 10 l.
This ligation mixture was incubated at RT for at least 2 hours or at 4oC
overnight.
5.2.7. Preparation of electrocompetent cells
Preparation of electrocompetent cells was performed as described in table 7.
1. Inoculate a single colony of E. coli (DH5, DH10B, XL10gold) into 10
ml LB medium and cultured at 37°C shaking overnight (250 rpm).
2. Inoculate the 2-10 ml overnight cultures into 2x1 liter prewarmed LB
medium and culture them at 37°C shaking until the O.D.600 reached
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0.6-0.8 (about 3 hours).
3. Chill the cells on ice for 10-30 minutes.
4. Centrifuge at 5000 rpm at 4°C for 20 minutes to harvest the cells.
5. Discard the supernatant, wash each pellet from 1 liter culture with 1
liter prechilled water (1:1 wash), then centrifuge at 5000 rpm at 4°C for
20 minutes.
6. Discard the supernatant, wash each pellet with 100 ml prechilled 10%
glycerol (1:10 wash), then centrifuge at 6000 rpm (Sorvall HS-4 rotor)
at 4°C for 10 minutes.
7. Discard the supernatant, wash each pellet with 20 ml prechilled 10%
glycerol (1:50 wash), then centrifuge at 6000 rpm at 4°C for 10
minutes.
8. Discard the supernatant, wash each pellet with 2 ml prechilled 10%
glycerol (1:500 wash), then centrifuge at 6000 rpm at 4°C for 5
minutes.
9. Aspirate the supernatant, resuspend each pellet in 2-3 ml 10%
glycerol. 50 l or 100 l resuspension was aliquoted into each tube on
ice, frozen in liquid nitrogen, and stored at –80°C.
Table 7. Preparation of electrocompetent E. coli cells.
5.2.8. Preparation of competent cells for heat shock transformation
Competent cells for heat shock transformation were prepared as described in
table 8.
1. Inoculate a single colony of E. coli (DH5 or XL-1 Blue, XL10gold) in
50 ml LB medium and culture at 37°C shaking overnight (250 rpm).
2. Transfer 4 ml of the overnight culture into 400 ml LB medium and
incubate at 37°C shaking to an O.D.600 of 0.35-0.4.
3. Make aliquots of the cultured medium into eight 50 ml prechilled sterile
polypropylene tubes (BD Falcon), and incubate them on ice for 5-10
minutes.
4. Centrifuge at 1600 g (3,000 rpm, Sorvall HS-4 rotor) at 4°C for 7
minutes.
5. Discard the supernatants, gently resuspend each pellet in 10 ml
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prechilled CaCl2 solution (60 mM CaCl2, 15% glycerol, 10 mM PIPES,
pH 7.0), and centrifuge at 1100 g at 4°C for 5 minutes.
6. Discard the supernatants, resuspend each pellet in another 10 ml
prechilled CaCl2 solution, and incubate them on ice for 30 minutes.
7. Centrifuge at 1100g at 4°C for 5 minutes.
8. Discard the supernatants, and resuspend each pellet completely in 2
ml prechilled CaCl2 solution.
9. Aliquot 200 l into each tube on ice, freeze immediately in liquid
nitrogen, and store them at –80 °C.
Table 8. Preparation of chemical competent E. coli cells.
5.2.9. Transformation of E. coli by electroporation
50 l competent cells were thawed on ice and transferred in a prechilled 0.1
cm electrode Gene Pulser Cuvette (Bio-Rad). 1 l DNA solution (1 ng/l) or
1.5 l ligation product was added directly to the competent cells and mixed
well by gently flicking. Then, the surface of the cuvette was completely dried
and the electroporation was performed using a Gene Pulser (Bio-Rad) with
following setting, 1.8 kV voltage, 200  resistance, 25 F capacitance.
Afterwards, 960 l prewarmed LB medium was immediately supplied to the
electroporated E. coli for recovery. The cells were recovered at 37°C rotating
for 1 hour, followed by plating 100 l and 900 l on separate plates.
5.2.10. Transformation of E. coli by heat shock
50-100 l competent cells were thawed on ice and transferred into a Falcon
polypropylene tube (BD Falcon). 10 ng pure DNA or 10 l ligation product was
directly added to the competent cells and mixed well by gently flicking. The
mixture was incubated on ice for 30 minutes, heat shocked at 42°C for 45
seconds, and incubated on ice for another 2 minutes. Then, 900 l
prewarmed LB or SOC medium (Invitrogen) was supplied to the heat shocked
cells, and incubated at 37°C rotating for 1 hour. These cells were
subsequently spun down at 3000 rpm for 2 minutes, resuspended in 200 l
medium and plated.
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5.2.11. Plasmid DNA isolation from E. coli
DNA from E.coli was purified using QIAGEN Plasmid Mini, Midi, Maxi, Mega,
Giga Kit (Qiagen), as described by the manufacturer.
5.2.12. Genomic DNA extraction from mammalian cells or mouse
tissues
Cultured mammalian cells in a 10 cm dish were trypsinized and washed twice
with PBS. Cell pellet was then resuspended in 1 ml cell lysis buffer (100 mM
Tris, pH 8.0, 200 mM NaCl, 5 mM EDTA, 0.2% SDS, freshly added 100 g/ml
Proteinase K) and incubated at 50°C shaking for 6 hours. Then, the lysis
product was extracted with 1 volume of phenol/chloroform/isoamylalcohol
(25:24:1) twice, and precipitated with 1 volume of isopropanol plus 0.1 volume
of 3 M NaAc, pH 5.2. The precipitated pellet was washed with 500 l 70%
ethanol, air dried, and dissolved in 50 l millipore H2O. The mouse tissue was
washed once with PBS before digestion in 500 l tissue lysis buffer (100 mM
Tris, pH 8.5, 200 mM NaCl, 5 mM EDTA, 0.2% SDS, freshly added 250 g/ml
Proteinase K) at 55°C with overnight shaking. Treatments were the same as
described above in mammalian cells.
5.2.13. Generation of a Er81Cre transgenic mouse line
The 2 kb upstream from the starting codon of mouse Er81 gene were
amplified by the Expand Long Template PCR kit (Roche) as a NheI/Not
fragment, then cloned in Cre-IRES-GFP-Intron-pA plasmid (Ashery-Padan et
al., 2000; Berger et al., 2004) in pSL1180 (Pharmacia). The Er81Cre mice
were generated by pronuclear microinjection. Transgenic mice were identified
by PCR analysis or GFP-fluorescence.
5.3. Method for RNA study
5.3.1. Total RNA isolation from eukaryotic cells or embryos
Total RNA from cultured cells or mouse tissues was isolated using RNeasy
Mini Kit (Qiagen), as described by the manufacturer.
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5.3.2. qRT-PCR
qRT-PCR (qPCR) analysis was performed using a QuantiTect Rev.
Transcription and QuantiTect SYBR Green PCR Kit (Qiagen) with a qPCR
Mastercycler (Eppendorf) according to manufacture ´s instructions. The assay
was done in triplicate and normalized to internal 18S (data in means ± s.d.).
The sequences of primers for qPCR are listed in table 2.
5.4. Methods for protein study
5.4.1. Expression and purification of GST-fused recombinant protein
GST-fused Trim11 protein was expressed in E. coli and purified as described
table 9.
1. Mouse Trim11 cDNA was inserted into pGEX-KG vector (Amersham)
between XhoI and HindIII sites in frame with GST.
2. Heat shock transformed the pGEX-KG-Trim11 construct into BL21 DE3
C41 competent cells. Inoculate a single colony into 100 ml LB medium
with 50 g/ml ampicillin, and culture at 37°C shaking overnight.
3. Add prewarmed LB medium with 50 g/ml ampicillin into the 100 ml
overnight culture up to 1 liter, and continuously incubate at 37°C
shaking to an O.D.600 of 0.7-0.8 (about 1 hour).
4. Add IPTG to a final concentration of 1 mM to induce the protein
expression at 25°C shaking for 6 hours (or at 37°C shaking for 2
hours).
5. Centrifuge at 5000 rpm at 4°C for 25 minutes to harvest the cells.
6. Briefly discard the supernatant, resuspend the pellet with the remaining
medium, and transfer the resuspension into a 50 ml Falcon tube.
7. Centrifuge at 4000 rpm at 4°C for 30 minutes. Discard the supernatant
and freeze the pellet at –20°C overnight.
8. Resuspend the pellet with 40 ml resuspension buffer (50 mM Tris, pH
7.5, 500 mM NaCl, 2 mM EDTA, freshly added protease inhibitor tablet)
on ice.
9. Sonicate the resuspension on ice for 5 x 1 minute with 1 cm tip using
Cell Disruptor B15 (Branson Sonifier) under the condition of Output
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Option 7 and 50 % Duty Cycle.
10. Ultracentrifuge in a vacuum environment at 25000 rpm at 4°C for 25
minutes using L7 Ultracentrifuge (Beckman).
11. Collect the supernatant, add 500 l prewashed Glutathione Sepharose
4B (Amersham), and incubate at 4°C rotating for at least 1 hour.
12. Centrifuge at 800 rpm at 4°C for 1 minute and discard the supernatant.
13. Wash with 15 ml prechilled washing buffer (50 mM Tris, pH 7.5, 1000
mM NaCl, 2 mM EDTA, freshly added protease inhibitor) twice.
Centrifuge at 800 rpm at 4 °C for 1 minute and discard the supernatant
in between.
14. Resuspend the beads with 5 ml washing buffer and transfer them into a
5 ml column (Pierce). Flow through the buffer and wash the beads in
the column once more with 4 ml washing buffer column (Pierce). Flow
through the buffer and wash the beads in the column once more with 4
ml washing buffer.
15. Elute the GST-Trim11 fusion protein by incubating the beads with 1.2
ml 20 mM Glutathione (Sigma) at 4 °C rotating for 1 hour. Collect the
elution.
16. Further elute the protein from the beads with another 2 ml 20 mM
Glutathione at 4°C rotating for another 1 hour. Collect the elution.
17. Measure the protein concentration with Bradford Assay (Bio-Rad), in
which 1 l of protein elution was mixed with 800 l H2O and 200 l
Bradford Reagent was added. Then, the O.D.595 of the sample was
measured and the concentration of protein was determined according
to the standard curve.
18. Aliquot the purified protein, freeze them in liquid nitrogen and store at
–80°C.
Table 9: Expression and purification of GST-fused Trim11 protein from E. coli.
5.4.2. Total protein extraction from mouse embryos
Mouse corties were homogenized briefly with a pipette, and sonicated on ice
with continuous pulses for 3-4x10 seconds in 100 l/cortex lysis buffer 2 (20
mM HEPES, pH 7.85, 30 mM NaCl, 10% glycerol, 0.2 mM EDTA, 1 mM DTT,
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and freshly added protease inhibitor) using a Cell Disruptor B15 and 3 mm tip.
The protein concentration of the soluble extracts was measure at an
absorbance of 280 nm using BioPhotometer (Eppendorf) and normalized
using BSA standards. The total protein extracts were aliquoted, frozen in
liquid nitrogen, and stored at –80°C.
5.4.3. In vitro transcription/translation
The reaction was performed using a TNT Reticulocyte Lysate System
(Promega). The reaction mixture contained 2 g maxiprep DNA, 4 l TNT
reaction buffer, 2 l amino acids mixture without methionine, 2 l amino acids
mixture without Leusine, 1.5 l RNasin, 1.5 l TNT SP6 or T3 or T7 RNA
polymerase, 50 l reticulocyte lysate, and the approrate volume of DEPC
treated H2O to a total volume of 100 l was mixed well by flicking and
incubated at 30°C for 2 hours.
5.4.4. Western blotting
Total protein extracts of mouse cortex or cultured cells were obtained by
either sonification or heating in SDS-PAGE sample buffer (2% SDS, 9 mM
Tris-HCl at pH 6.8, 20% glycerol, 0.02% bromophenol blue, 0.1 M DTT) with a
cocktail of protease inhibitors (Roche). The supernatant from the soluble
fraction was collected after centrifugation at 10000 g for 2 min. The protein
concentration was estimated by the Bradford procedure (BioRad). Proteins
(20-50 μg) were fractionated by SDS-PAGE and blotted onto transfer
membranes (Millipose) for western blot analysis. Membranes were incubated
with antibodies against primary and secondary antibodies (table 3). Antibodies
were detected by chemiluminescence kit from Pierce. Quantifications were
normalized to the level of actin. Blots were re-used by using a re-BlotWestern
Blot Recycling kit (Chemicon).
5.4.5. Luciferase assay
NIH-3T3 and Hela cells or the cortex primary cells were lysed and used for
Luciferase activity quantification with a luciferase assay system (Promega)
and Lumat LB9501 luminometer (Berthold), according to manufacturer
`instructions.
 Materials and Methods
                                                                                                                            
93
5.5. Methods for study of protein-protein interaction
5.5.1. Yeast two-hybrid screening
The yeast-two-hybrid screening was performed using the ProQuest two-hybrid
system (Invitrigen).
5.5.1.1. Construct for the two-hybrid screening
The Sal1/NotI cDNA fragment of Pax6PD, which encodes murine Pax6
without the pair domain was cloned into the pDBLeu vector (Invitrigen) in
frame with the GAL4 DNA binding domain (Fig.18A). The cloning and
expression of recombinant protein in yeast were verified by sequencing and
western blot analysis, respectively.
The pDBLeu-Pax6PD construct was used as a bait plasmid in the yeast two-
hybrid screening. A cDNA library of the E15.5 Mouse cortex is harbored in the
pEXP-AD502 vector (EvoQuest Custom cDNA library, Invitrogen) to be
expressed as a transactivation domain fusion protein.
5.5.1.2.  Evaluation of transformation efficiency of MaV203 competent
cells
The cotransformation efficiency of MaV203 competent cells was evaluated as
described in table 10.
1. Thaw the PEG/LiAc (Invitrogen) solution at RT and mix the solution
well before dispensation.
2. Thaw the MaV203 competent yeast cells (library scale, Invitrogen) in a
30°C incubator for 90 seconds (or less). Invert the tube several times
immediately, and transfer 100 l into a 1.5 ml eppendorf tube.
3. Add 1 g pDBLeu- Pax6PD and 1 g pEXP-AD502 vector to the
competent cells, mix well by flicking the tube.
4. Add 600 l PEG/LiAc solution into the mixture, mix well by inverting the
tube until the competent cells are totally homogenous
5. Incubate in a 30°C incubator for 30 minutes, inverting the tube every 10
minutes.
6. Add 35.5 l DMSO and mix well by inverting the tube.
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7. Heat shock the cells at 42°C for 20 minutes, inverting the tube
occasionally.
8. Centrifuge the tube at 2000 rpm for 5 seconds and aspirate the
supernatant.
9. Resuspend the pellet in 1 ml autoclaved H2O and make 1:10, 1:100
and 1:1000 dilutions.
10. Plate 100 l from the crude resuspension and each dilution onto the
selection medium plate SD-L-W (21.36 g SD medium (Clontech), 0.512
g DO-Leu-Trp (Clontech), 17.6 g Agarose (Invitrogen) in a total volume
of 800 ml, autoclaved, 25 ml/dish). Medium plate SD-L-W (21.36 g SD
medium (Clontech), 0.512 g DO-Leu-Trp (Clontech), 17.6 g Agarose
(Invitrogen) in a total volume of 800 ml, autoclaved, 25 ml/dish).
11. Incubate the plate upside down at 30°C for 72 hours.
Table 10. Evaluation of the cotransformation efficiency of MaV203 yeast
competent cells
5.5.1.3. Determination of the 3-Amino-1,2,4-Triazole (3AT)
3AT was used to inhibit background colonies during the first round of library
screenning. 2 single yeast colonies from five control strains a-e (Fig.18;
Invitrogen) as well as yeast cotransformed with pDBLeu-Pax6PD and pEXP-
AD502 vector on SD-L-W plates were patched onto SD-L-W-H plates (8.01 g
SD medium, 0.186 g DO-Leu-Trp-His (Clontech), 6.6 g agarose in a total
volume of 300 ml, autoclaved, 25 ml/dish) supplemented with different
concentrations of 3AT (0 mM, 10 mM, 25 mM, 50 mM, 60 mM, 75 mM, 100
mM, diluted from 2 M stock). After incubation for 18 hours at 30°C, the highest
3AT concentration inhibiting the growth of control strain e and permitting the
growths of other control strains was selected for the library screen. 60 mM
3AT was used in this study.
5.5.1.4. Extraction of total protein from yeast
Yeast total protein was extracted as described in table 11.
1. Inoculate a single colony into 5 ml proper broth and incubate at 30°C
shaking overnight.
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2. Check the O.D.600 of overnight culture, and apply 5 O.D. yeast cells for
the protein extraction (If O.D.600=1.0, use 5 ml cultured cells; If
O.D.600=2.0, use 2.5 ml).
3. Centrifuge at 13000 rpm for about 10 seconds to pellet the cells.
4. Aspirate the supernatant, resuspend the pellet in 180 l 2 M NaOH
containing 5% -mercaptoethanol, and incubate on ice for 10 minutes.
5. Add 20 l 110% TCA (w/v) to precipitate the proteins and incubate on
ice for 10 minutes.
6. Centrifuge at 13000 rpm for 1 minute and carefully remove the
supernatant.
7. Neutralize the pellet by resuspending it in 100 l 1 M Tris, pH 11.0.
8. Centrifuge at 13000 rpm for 1 minute and carefully remove the
supernatant.
9. Resuspend the pellet in 100 l 2x SDS loading buffer, incubate at 95°C
for 5 minutes.
10. 5-10 l (0.25-0.5 O.D.) sample was subjected to SDS-polyacrylamide
gel electrophoresis and western blotting.
Table 11. Extraction of total protein from yeast cells
5.5.1.5.  cDNA library screen on histidine minus medium
The first round of the cDNA library screen was performed on plates lacking
leucine, tryptophan and histidine, and supplemented with 60 mM 3AT as
described in table 12.
1. Heat shock transform the MaV203 competent yeast cells with pDBLeu-
Pax6PD as described above, then plate on SD-L medium (8.01 g SD
medium, 0.207 g DO-Leu (Clontech), 6.6 g agarose, autoclaved, 25
ml/dish) and incubate for 48 hours.
2. Inoculate a single pDBLeu-Pax6PD transformant into 100 ml SD-L
broth, and incubate at 30°C overnight.
3. Check the O.D.600 of the inoculated SD-L broth (1:5 dilution)
4. For good competent cells, the O.D.600 of the starting culture in YEPG
broth (10 g Yeast extract, 20 g Peptone 140, 20 g D-glucose, 20 mg
uracil, 20 mg adenine sulphate in a total volume of 1 liter, autoclaved)
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should be 0.2-0.3.
5. Incubate at 30°C for 4.5 hours with shaking.
6. Centrifuge 200 ml culture at 2,500 rpm for 2 minutes, discard the
supernatant and wash cells with 10 ml LTS buffer (10 mM Tris, pH 7.4,
1 mM EDTA, 0.1 M LiAc, 1 M Sorbitol).
7. Centrifuge at 2,500 rpm for 2 minutes, discard the supernatant,
resuspend the cells in 1.1 ml LTS buffer, and equally distribute into 22
tubes each with 50 l.
8. Centrifuge at 13,000 rpm for about 10 seconds, and aspirate the
supernatants.
9. Add 250 l 50% PEG 4000, 36 l 1 M LiAc, 20 l 2 mg/ml carrier
Salmon Sperm DNA (Stratagene) into each tube.
10. Add 50 l DNA solution containing 5 g maxipreped library DNA into
each tube. Then use a pipette to destroy the pellet slightly, and mix well
by vortexing.
11. Incubate at 30°C for 45 minutes, inverting the tubes occasionally.
12. Heat shock at 42°C for 20 minutes, inverting the tubes occasionally.
13. Centrifuge at 13000 rpm for about 10 seconds, and aspirate the
supernatants.
14. Wash each pellet with 100 l H2O or TE buffer (10 mM Tris, pH 7.4, 1
mM EDTA) without destroying the pellets.
15. Resuspend each cell pellet in 0.5 ml YEPG broth and recover the
transformed yeast cells at 30°C for 3 hours with shaking.
16. Centrifuge at 13,000 rpm for about 10 seconds, aspirate 0.3 ml
medium, and resuspend the pellet in the remaining 0.2 ml medium.
17. Plate each resuspension onto a 15 cm SD-L-W-H plate supplemented
with 60 mM 3AT (40 ml medium per 15 cm dish). Incubate the plates at
30°C for 72 hours.
18. One tube was reserved to check the transformation efficiency before
the last centrifugation. 20 l from the 500 l resuspension was diluted
1:10, 1:100, 1:1000, and 200 l of each dilutions was then plated onto a
SD-L-W plates.
Table 12. The first round of cDNA library screen on histidine minus medium
 Materials and Methods
                                                                                                                            
97
5.5.1.6. cDNA library screen by X-gal assay
The second round of the cDNA library screen, a X-gal assay, was performed
as described in table 13.
1. Inoculate positive colonies from the first round of screen onto numbered
SD-L-W plates. Also inoculate all these colonies onto Nytran nylon
transfer membranes (Schleicher&Schuell BioScience) that were wet
and tightly attached to SD-L-W medium. Incubate the inoculated plates
at 30 °C overnight.
2. Proper amount of X-gal (Applichem) was dissolved in 100 l DMFA,
and then diluted in 7 ml Z-Buffer (16.1 g Na2HPO4.7H2O (or 10.7 g
Na2HPO4.2H2O), 5.5 g NaH2PO4.H2O, 0.75 g KCl, 0.25 g MgSO4.7H2O
in a total volume of 1 liter) to a final concentration of 0.3-1 mg/ml.
3. Distribute the 7 ml X-gal in Z-Buffer onto a Whatman paper in a 9 cm
dish.
4. Freeze the nylon membrane with yeast colonies inoculated in liquid
nitrogen for 1 minute.
5. Place the frozen membrane onto the Whatman paper, and incubate at
30°C.
6. Check the X-gal staining of the colonies after 10 minutes to overnight
incubation.
Table 13. The second round of cDNA library screen using X-gal assay
5.5.1.7. DNA extraction from yeast cells
1.5 ml overnight culture was pelleted by centrifugation at 13000 rpm for about
10 seconds, and resuspended in 30 l STES buffer (100 mM Tris, pH 8.0, 1
mM EDTA, 100 mM NaCl, 0.1% SDS). The resuspension was vortexed, spun
down at 13000 rpm for about 10 seconds, and resuspended in another 30 l
STES buffer. Acid washed glass beads were added to 80% volume, followed
by vortexing the sample for 5x1 minute. Then, 200 l TE buffer was added,
and DNA was recovered by phenol/chloroform/isoamylalcohol (25:24:1)
extraction and isopropanol precipitation. For the isolation of a certain plasmid,
the extracted DNA was transformed into E. coli and selected on an ampicillin
or kanamycin plate.
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5.5.2. Analysis of protein-protein Interaction
5.5.2.1. GST pull-down assay
Trim11 or GST protein (control) was incubated with 50 l of the pre-washed
Glutathione Sepharose 4B beads in 500 l pull-down binding buffer containing
20 mM Tris (pH 7.5), 150 mM NaCl, 1 mM EDTA, 0.1% NP-40, proteinase
inhibitors (Roche) at 4°C with rotating overnight for coupling. Hela cells were
transfected with CMV-Pax6. After 48 hours of culturing, proteins were
extracted in the M-PER mammalian protein extraction reagent (Pierce). Equal
amounts of mammalian expressed proteins were added to bead-coupled GST
or GST-Trim11 and incubated for 2 h at 4oC in pull-down buffer. Afterwards
beads were washed three times with a pulldown washing buffer, containing 20
mM Tris (pH 7.5), 100 mM NaCl, 1 mM EDTA, 0.1% NP-40, proteinase
inhibitor (Roche) at 4°C. Bound proteins subsequently were eluted from the
beads with 40 l 2xSDS loading buffer by heating at 95°C for 5 minutes, then
centrifuged at 13 000 rpm for 1 minute.
5.5.2.2. Immunoprecipitation
For immunoprecipitation experiments, CMV-Pax6  and HA-Trim11 were
transiently cotransfected and harvested after 48 hours. The
immunoprecipitation was performed using the ProFound HA Tag IP/Co-IP kit
(Pierce), according to the manufacturer ´s instruction. The experiments were
carried out in the presence of the proteasome inhibitor MG132 (20 M).
Elutants from the pull-down and the immunoprecipitation assays and
corresponding inputs were electrophoresed using SDS-PAGE and subjected
to western blot analyses with approriate antibodies.
5.6. Methods for study of protein-nuclei acids association
5.6.1. Electrophoretic mobility shift assay (EMSA)
EMSA was performed as described by Bäumer et al (2003) with some
modifications. Briefly, Pax6 proteins were overexpressed using the TNT in
vitro transcription and translation system (Promega) according to the
manufacturer’s instruction. Double-stranded oligonucleotides (see table 2)
were end-labeled using polynucleotide kinase and gramma-P32ATP. The
 Materials and Methods
                                                                                                                            
99
binding reaction was performed for 1 hour on ice in a binding buffer (25 mM
HEPES pH7.4, 10% glycerol, 75 mM NaCl, 0.25 mM EDTA, 10 g/ml, 1 mM
DTT, 0.1% Nonidet P-40, 1 mM MgCl2, protease inhibitor cocktail) with 5 g
poly-dI-dC, 25000 cpm of the double-stranded oligonucleotide and 5 l of
Pax6 TNT protein. For the antibody shift analysis 0.5 l of Pax6 polyclonal
rabbit antibodies (Babco) were added and samples incubated for an additional
15 min. Samples were load on 4% TAE polyacrylamide gel. Complexes were
separated at 10V/cm. The gel was dried and processed for autoradiography.
5.6.2. Chromatin immunoprecipitation (ChIP) assay
Chromatin extraction was prepared from E15.5 mouse cortices.
Immunoprecipitation was performed using a ChIP assay kit according to the
manufacture's instruduction (Upstate Biotechnology). Polyclonal Pax6
antibodies (BABCO) or pre-immune serum (as control) were used for
immunoprecipitation (10 g antibody per immunoprecipitation). Amplification
was performed using primer pairs listed in the table 2.
5.7. Methods for study of protein ubiquitylation
5.7.1. Measurement of the protein half-life
24 hour after transfection with the indicated combination of plasmids,
cycloheximide (20 μg/ml) was added to the Hela cells (Fig.19A). Protein levels
were determined by collecting cells at the different time points and performing
immunoblotting as described above. The relative amount of Pax6 protein was
evaluated by densitometry.
5.7.2. In vivo ubiquitylation assay
Hela cells were transiently transfected with plasmids of His-Ub, HA-Trim11
and Flag-Pax6 as indicated in Fig.19B. 40 hours after transfection, cells were
treated with MG132 (20 M) for an additional 8 hours and harvested. The
harvested cells were used for immunoprecipitatation using the FLAG Tagged
Protein Immunoprecipitation Kit (Sigma), according to the manufacturer ´s
instroduction. Elutants of the immunoprecipitation and Inputs were served for
the immunoblot analysis.
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5.7.3. Steady-state protein level analysis
Hela cells were cotransfected with CMV-Pax6 and either HA-Trim11 or an
empty plasmid. 24 hours after transfection cells were treated with MG132 (20
M) for additional twenty-four hours. Cell lysates were subjected to western
blotting. PAX6 proteins were detected by using an anti-Pax6 antibody. The
same blots were re-probed with anti-ß-Actin antibody as a loading control.
5.8. Methods for cell culture
5.8.1. Cell culture and cell transfection
NIH-3T3 and Hela, Neuro2A cells were maintained and cultured in DMEM
medium plus 10% FCS. Cells were transfected by using Lipofectamine 2000
(Invitrogen) according to supplier´s instroduction.
5.8.2. Primary culture of cortical cells and cell electroporation
The two telencephalic hemispheres were isolated under sterile conditions in
Ca2+/Mg2+-free HBSS containing 10 mM HEPES. After twice washing with
fresh Ca2+/Mg2+-free HBSS containing 10 mM HEPES, cells were incubated
for 18 min at 37°C in 0.25% Trypsin/EDTA (Sigma). The tissue was then
dissociated mechanically with a fire-polished Pasteur pipette coated with
serum, centrifuged for 5 min at 1000 rpm, washed and resuspended in DMEM
medium plus 10% FCS. Cortical primary cells were electroporated with the
nucleotransfection device (Amaxa). Electroporated cells were cultured in
different conditions. Dissociated cells were cultured on coverslips coated with
poly-D-lysine and with Sato medium (DMEM, 100 g/ml albumin, 100 g/ml
apo-transferrin, 16 g/ml putrescine, 0.06 ng/ml progesterone, 40 ng/ml
selenium, 5 g/ml insulin, 1 mM sodium pyruvate, 2 mM L-glutamine) for 3
days for cortical progenitors (Nestin and Pax6-positive cells) and neuron
differentiation (Tuj-positive cells) (Fig.20, Bottenstein & Sato, 1979). To obtain
mature neurons dissociated cells were cultured in either the Sato medium or
the mature neuron medium (Neurobasal-A medium supplemented with 10 mg
insulin, 10 mg transferrin, 5% FCS, 2% B27, 2 mM GlutaMAX, 5 μM cytosine
arabinoside). Cells were cultured on coverslips coated with poly-L-ornithine
and with Sato medium or D-MEM medium containing 1g/l D-Glucose plus 10
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mM HEPES and 10% FCS for astrocyte differentiation.
5.9. Methods for histological study
5.9.1. Manipulation of the mouse embryo and brain
Pregnant mice with the desired stage of embryos or postnatal mice were
killed. Embryos or brains were washed in ice-cold PBS. Additionally, a tissue
sample from either the yolk sack or tail was taken from each individual
specimen and processed for the extraction of genomic DNA and genotyping.
Mouse embryos and brains were fixed in 4% PFA and washed in PBS before
embedding.
5.9.2. Cryo embedding and sectioning
Mouse embryos and brains were incubated in 30% Sucrose/PBS for cryo-
protection. The specimens were thenembedded in blocks. Sectioning was
performed with a cryostat (CM 3050 S, Leica). After cutting, sections were
allowed to dry on a 28°C-heating plate for 30 min. Afterwards, the slides were
stored at –20°C to –80°C.
5.9.3. Paraffin embedding and sectioning
Mouse embryos and brains were dehydrated in an ascending stepwise of
ethanol and incubated overnight in isopropanol. They after that were
incubated in 25% Toluol/Isopropanol, 50% Toluol/Isopropanol, 75%
Toluol/Isopropanol and 100% Toluol for 1 hour for each step. Then, the
samples were incubated in liquid paraplast at 60°C for three days (changing
the wax every day). The samples were embedded in appropriate paraplast-
filled blocks. The blocks were stored at RT. Paraffin-sections were performed
with a microtome (Leica). Sections with thicknesses from 5 m to 10 m were
transferred to a heated water-bath (43°C). After sections had spread, they
were collected on glass slides. Slides  were then dried overnight at 37°C. The
dried sections were stored at 4°C.
5.9.4. Cresylviolet staining
Paraffin-sections were dewaxed in histoclear and rehydrated in decreasing
concentrations of ethanol. After incubating the sections for 15 minutes in 50%
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K2SO3 and rinsing in H2O, the samples were stained for 15 minutes in 1,5%
Cresylviolet (Sigma) in 10 mM Sodium acetate/10mM Acetic acid (Acetate
buffer). The sections then were incubated in Aceteate buffer (three times for
one minute) and washed in H2O. After excess Cresylviolet was removed by
incubation in 70% Ethanol for 1 minutes, the sections were dehydrated in
100% Ethanol and cleared in Histoclear (5 minutes each step). Stained
sections were then mounted on a glass coverslip (Marienfeld), using Eukitt
(Kindler) mounting medium.
5.9.5. Insitu hybridization
10-20 g plasmid DNA was linearized by incubating with 40 u restriction
enzyme at 37 °C for 3 hours, purified with the phenol extraction or the PCR
Purification Kit (Qiagen), and eluted in 10 l TE. 1 l elution was loaded on an
agarose gel to check the linearization efficiency. Plasmids for probes and
restriction enzymes for plasmid linearization are listed in table 4.
5.9.5.1. Dig-labeling insitu hybridization
Linearized template-DNA was transcribed in vitro to generate the anti-sense-
mRNA probes, by using Digoxygenin-labelled (DIG) UTP´s. The in vitro-
transcription reaction contain: 14 l of DEPC-treated H2O, 2 l of 10X
transcription buffer (Roche), 2 l of DIG-Nucleotide mix (Boehringer), 1 g of
linearized template DNA, 0.5 l of RNAse inhibitor (Promega), 1 l of RNA
polymerase (Roche). The reaction was incubated for 2 hours at 37°C.
Afterwards (in order to check the efficency of anti-sense mRNA synthesis) an
aliquot was run on a 1% Agarose gel. The reaction-mix was further incubated
with 2 l/reaction DNAse I for 15 minutes at 37°C (to degrade excessive
template DNA). The reaction was then diluted with 100 l TE, 10 l 4M LiCl
and the RNA was precipitated by adding 300 l 100% Ethanol, followed by
incubation at –20°C for 2 hours. After spinning the tubes for 20 minutes at
13000 rpm at 4°C, the pellet was washed in 70% Ethanol and briefly air-dried.
The RNA-pellet was then resuspended in 50 l DEPC-treated H2O and kept at
–20°C. ISH with DIG-labeled probe was performed as described in the table
13.
Treatment and solution Condition Duration
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1st Day
For Cryo-sectioning slide
4% PFA RT 15 min
PBS x 2 RT 5 min x 2
Proteinase K (50ml of 1M Tris-Cl pH 8.0, 10ml of
0.5 EDTA, add to 1l Milipore water, 0.5ml of
Proteinase K (10mg/ml) (add fresh)
37oC 4 min
For Paraffin-sectioning slide
Histoclear x 3 RT 7 min x 3
100% Ethanol RT 2 min  x 2
96% Ethanol RT 1 min
90% Ethanol RT 1 min
70% Ethanol RT 1 min
50% Ethanol RT 1 min
Proteinase K at 37oC 37oC 20 min
Steps for both Cryo-sectioning  and Paraffin-sectioning slides
Glycin (250 ml of PBS, 2.5ml of 20% glycine) RT 5 min
PBS x 2 RT 5 min x 2
Postfixation (250ml of 4% PFA, 1ml of 50%
Glutaraldehyde)
RT 5 min
PBS x 2 RT 5 min x 2
Prehybridization (50ml of formamide, 25ml of 20 x
SSC pH4.5, 1g of blocking powder (Boehringer),
1ml of 0.5M EDTA, 1ml of 100 mg/ml tRNA, 0.1ml of
100 mg/ml Heparin, 0.1ml of Tween-20, 1ml of 10%
CHAPS, add DEPC-water to 100ml)
70oC >2 hours
Probe in hybridization buffer 70oC ON
2nd day
2xSSC (25ml of 20xSSC pH4.5, add milipore
water to 250 l)
RT 5 min
2x SSC/50% Formamide x 3 65oC 30 min x 3
KTBT (100ml of 1M Tris-HCl pH7.5, 60ml of 5M
NaCl, 20ml of 1M KCl, 20ml of Tween-20, add water
RT 10 min
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to 2l, autocalave all components, and mix before
using)
Blocking Reagent (8ml KTBT, 2ml Sheep Serum RT >2 hours
Anti-DIG antibody (Roche) in Blocking Reagent
(1:2000)
4oC ON
3rd day
KTBT x 3 RT 5 min x 3
KTBT x 3 RT 30 min x 3
NTMT plus Levamisole x 3 (NTMT: 100ml of 1M
Tris pH 9.5, 20ml of 5M NaCl, 50ml of 1M MgCl2,
1ml of Tween-20, add water to 1l; add freshly 0.24 g
Levamisole
RT 5 min x 3
NTMT plus Levamisole/ NBT/BCIP (10ml NTMT, 2.4
mg Levamisole, 0.2ml NBT/BCIP (Roche).
RT As
desirable
PBT x 4 RT 5 min x 4
Mounting in Mowiol
Table 13. Procedure for ISH with DIG-labeled probe, (x: repeated time)
5.9.5.2. Radioactive-labeling insitu hybridization
For the synthesis of radioactively labelled mRNA probes, the linerarized
template-DNA´s (Table 4) were transcribed in a reaction containing: 10 l of
DEPC-treated H2O, 2 l of 10X transcription buffer (Roche), 100 M of DTT
(Boehringer), 80 Ci of 35S-UTP (Amersham), 1g of linearized template
DNA, 10 U of RNAse inhibitor (Promega), 10 U RNA polymerase (Roche).
The reaction mix was incubated for 60 minutes at 37°C. Afterwards, 1 l yeast
tRNA (10 mg/ml) and 2 l DNAse I (Promega) were added and incubated for
15 minutes at 37°C. The reaction-mix was then purified using G50 columns
(Amersham) and the final volume was adjusted to 50% Formamide/50 mM
DTT. The radioactivity of the probe was measured in a scintilation counter
(Beckmann) and contained at least 2x107 cpm. ISH with radioactively labelled
probe was performed as described in table 14.
Treatment and solution Condition Duration
1st Day – Prehybridization and hybridization
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Histoclear x 2 RT 7 min x 2
100% Ethanol RT 2 min
96% Ethanol RT 2 min
90% Ethanol RT 2 min
70% Ethanol RT 2 min
50% Ethanol RT 2 min
30% Ethanol RT 2 min
Saline RT 5 min
PBS RT 5 min
PFA RT 20 min
PBS x 2 RT 5 min x 2
Proteinase K RT 7 min
PBS x 2 RT 5 min x 2
PFA RT 5 min
PBS RT 5 min
Acetylation mix (6.25 ml Triethanolamine, 1.25 ml
Acetic acid, add milipore water to 500 ml)
RT 10 min
Saline RT 5 min
PBS RT 5 min
30% Ethanol RT 2 min
50% Ethanol RT 2 min
70% Ethanol RT 2 min
90% Ethanol RT 2 min
96% Ethanol RT 2 min
100% Ethanol RT 2 min
Probe (5x104 cpm/l) in hybridization buffer (0.2 g
PVP, 0.2 g Ficoll, 1.38 g NaH2PO4 pH 6.8, 50 mM
EDTA, 3 M NaCl, 0.1 M Tris pH 8, 1ml of
formamide, 0.2 ml of 1M DTT, 0.4 ml of 50%
dextransulfate, 1 l of tRNA, plus water to 2 ml)
50oC ON
2nd day: Washes
50% Formamid/2xSSC/-Mercaptoethanol 37oC 15 min
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65oC 30 min50% Formamid/2xSSC/-Mercaptoethanol
37oC 2 hours
NTE 37oC 15 min
NTE plus RNAse 37oC 15 min
NTE 37oC 15 min
50% Formamid/2xSSC/-Mercaptoethanol 37oC 30 min
2 x SSC RT 15 min
0.1 x SSC RT 15 min
30% Ethanol RT 2 min
50% Ethanol RT 2 min
70% Ethanol RT 2 min
90% Ethanol RT 2 min
96% Ethanol RT 2 min
100% Ethanol RT 2 min
3rd Day: Dipping
Dipping solution 42oC
in dark
4th Day: Dipping
1% Acetic acid RT 1 min
30% Sodiumthiosulphate RT 3 min
dH2O x 3 RT 1 min x 3
dH2O x 3 42
oC 1 min x 3
Giemsa staining-solution (4% Giemsa stock-solution
plus 40 mM Sodium phosphate buffer, pH6)
RT 30 min
In tap dH2O RT 30 min
Mounting in Eukitt mounting medium
Table 14. Procedure for ISH with radioactive-labeled probe, (x: repeated time)
5.9.6. Immunostaining
5.9.6.1. Immunohistochemistry (IHC)
Paraffin-sections were dewaxed in Histoclear (Vogel), rehydrated in a seria of
ethanol solution containing decreasing amount of alcohol and rinsed in PBS.
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Cryosections were washed in PBS and afterwards postfixed in 4% PFA/PBS
for 10 minutes. With some primary antibodies section were boiled in Antigen-
Unmasking solution (Vector). The sections were then blocked in a solution
containing PBT (PBS + 0,1% Triton 100) and 10% FCS for 2 hours. Diluted
primary antibodies were incubated on the slides for overnight at 4°C in
blocking solution. After rinsing in PBT, the sections were incubated in diluted
secondary antibodies in blocking solution for 1-2 hours at room temperature.
Before mounting, the sections were rinsed again in PBT and sealed with
Vectashield mounting-medium, containing DAPI or Propidium Iodide (as
nuclear counterstain) (Vector). The mounted sections were kept at 4°C,
protected from light.
5.9.6.2. Immunofluorescence and index of the counted cells
Cells grow on cover slips were fixed in 4% PFA, permeabilized with 0.5%
Triton X-100 in PBS, and blocked with 10% FCS in PBT. Cells were then
incubated overnight in primary antibodies followed by 1 h in secondary
antibodies. Cover slips were mounted onto glass slides by using the
Vectashield mounting medium with DAPI (Vector laboratories).
To compare the index of the counted cells for different markers in the
experiment of the overexpression of Trim11 and the corresponding controls,
cortical primary cells were stained with antibodies as described and
counterstained with the nuclei marker DAPI. Images with objective of 20x
were taken using BX60 fluorescence microscope. Antibody-positive cells and
total cells as DAPI-positive were counted and processed using analysis
software. The index of markers was calculated by dividing the total number
antibody-positive cells by the total number cells showing overexpression of
Trim11 and the corresponding controls. Data shown as means ± s.d. P values
were evaluated by using a Student ´s t-test.
5.9.7. In ovo chick electroporation
Fertilized chick eggs were incubated at 38°C in a humid incubator for 36-44
hours to reach stage HH9-11 (Hamburger and Hamilton, 1951). 2.5 g/l DNA
Er81-Luc plus 2.5 g/l of CMV-Pax6 or CMV-Gfp in PBS supplemented with
1 mM MgCl2 and 25-50 ng/l Fast Green were pipetted into a microinjection
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glass needle. The needle then assembled in Pneumatic PicoPump PV820
pump system (World Precision Instruments). After incubation, an egg was
held on a stand oriented so that the embryo sits on the top of the yolk. A 5 ml
syringe  (Terumo) was used to aspirate 2.5 ml albumin from the egg. About 2
cm2 of shell above the embryo was removed. Some drops of 1xTyrode buffer
(8 g NaCl, 0.2 g KCl, 0.271 g CaCl2.2H2O, 0.05 g NaH2PO4.2H2O, 0.2 g
MgCl2.6H2O, 1 g glucose in a total volume of 1 liter) were applied on the
embryo to prevent drying, and 1:75 diluted black ink (Higgins) in 1xTyrods
buffer was injected with a 1 ml syringe (Terumo) into the yolk right beneath
the embryo to visualize it. Subsequently, a small hole was carefully made in
the vitelline membrane using a 0.125 mm diameter wolfram-draht needle
(Agar Scientific) making the neural tube accessible. A parallel platinum
electrode (Aldrich) with 5-6 mm length, 0.25 mm diameter, and 7 mm distance
between two electrodes was placed onto the vitelline membrane flanking the
embryo in parallel with neural tube, pressed down to the same horizontal level
with the neural tube, and several drops of 1xTyrods buffer were applied on
each electrode. Afterwards, DNA solution was injected into the neural tube,
and 5 square electric pulses were giving by a Electro Square Porator ECM830
electroporator (BTX) with following setting of 33 V, 50 miniseconds/pulse with
950 miniseconds intervals. Finally, the window on the shell was tightly sealed
with tape, and the electroporated embryo was further incubated for 48 hours
to reach stage HH18-20. The surviving embryos were collected and analyzed
by immunohistochemistry. At least 10 electroporated embryos were analysed
in each experiment.
5.9.8. X-Gal staining
Mouse brains were prepared and fixed in fixing solution (37% formaldehyde,
25% glutaldehyde, 10% NP-40, 20x PBS). X-Gal staining was performed on
whole brain. The ß-galactosidase-activity was developed in staining solution
(PBS, 1 mg/ml X-Gal, 2mM MgCl2, 0,01% SDS, 0,02% NP40, 5 mM
K3Fe(CN)6, 5mM K4Fe(CN)6), for several hours to overnight at 30°C and
protected from light. The samples were washed in PBS and stored in 80%
glycerol at 4°C.
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5.9.9. BrdU labelling
BrdU (Sigma) uptake experiments were done by intraperitoneal injection (100
l of 0.014 g BrdU in 1 ml PBS /10 g body weight) into pregnant mice. For
pulse-labelling of SGL neurons, pregnant mice were injected at E16.5 (time
point of the generation of SGL peaks) or E18.5 (predominantly L2-3 are born).
Newborns of the injected mice were sacrificed at P10. Brains of newborns
were then dissected and embedded. Sections were cut and then used for
immunohistochemistry
 Abbreviations
                                                                                                                            
110
Abbreviations
Short name Full name
3AT 3-Amino-1, 2, 4-Triazole
AVE Anterior visceral endoderm
bHLH Basic helix-loop-helix
BPs Basal progenitors
CC Corpus callosum
CGE Caudal ganglionic eminence
ChIP Chromatin immunoprecipitation
cKO Conditional knockout
CNS Central nervous system
CP Cortical plate
CR Cajal-Retzius
CSMN Corticospinal motor neurons
D/V Dorsoventral
DG Dentate girus
DIG Digoxygenin
DIV Days of in vitro culture
dLGE Dorsal lateral ganglionic eminence
dLGN Dorsal lateral geniculate nucleus
DP Dorsal pallium
EMSA Electrophoretic mobility shift assay
Fr Frontal cortex
GE Germinative epithelium
H&E Haematoxilin & eosin
HD Homeobox domain
Hi Hippocampus
HiSVZ Hippocampal SVZ
ICC Immunocytochemistry
IGL Infragranular layer
 Abbreviations
                                                                                                                            
111
IHC Immunohistochemistry
INs Interneurons
IPs Intermediate progenitors
ISH Insitu hybridization
IZ Intermediate zone
L1-6 Layer1-6
LGE Lateral ganglionic eminence
LMS Lateral migratory streams
LOF Loss-of-function
LP Lateral pallium
MGE Media ganglionic eminence
MP Medial pallium
MZ Marginal zone
NE Neuroepithelial cells
OB Olfactory buld
Oc Occipital
Par Parietal cortex
PD Pair domain
POA Preoptic Area
PP Preplate
pPv Posterior periventricular zone
pPV Posterior periventricular region
PSPB Pallial-subpallial border
PTM Post-translation modification
qPCR Quantitative RT-PCR
RG Radial glia
RMS Rostral migratory streams
RT Room temperature
Sey Small eye
SGL Subgranular layer
SGZ Subgranular zone
shRNA Short hairpin RNA interference
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smRNA Small modulatory RNA
SS Somatosensory
Str.L.M Stratum lacunosum-moleculare
Str.M Stratum moleculare
Str.or Stratum oriens
Str.Pir Stratum pyramidale
Str.Rad Stratum radiatum
SVZ Subventricular zone
UPS Ubiquitin-proteasome system
vLGE Ventral lateral ganglionic eminence
VP Ventroposterior
VZ Ventricular zone
WB Western blot
WM White matter
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